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ABSTRACT 
 
Iron sulfur (Fe-S) clusters are essential cofactors that function in electron 
transport, catalyzing substrate turnover, environmental sensing, and initiating radical 
chemistry. Elaborate multi-component systems have evolved to protect organisms from 
the toxic effects of free iron and sulfide ions while promoting the efficient biosynthesis 
of these cofactors. The in vivo loss of frataxin (FXN) function results in depleted activity 
of Fe-S enzymes and is directly linked to the fatal and incurable neurodegenerative 
disease Friedreich’s ataxia (FRDA).  
Previously, our lab discovered the cysteine desulfurase and Fe-S assembly 
activities of the human Fe-S assembly complex (SDU), which consists of the cysteine 
desulfurase complex NFS1-ISD11 and scaffold protein ISCU2, are greatly stimulated by 
FXN binding and forming the SDUF complex. This dissertation’s objectives were to 
identify critical FXN interactions for binding and activation of the SDU complex, 
investigate the interprotein sulfur transfer reaction between NFS1 and ISCU2, and 
provide mechanistic details of Fe-S assembly on the SDUF complex.  
First, surface residues on FXN were substituted with alanine or glycine and the 
ability of each variant to bind and activate the SDU complex was assessed. These 
experiments revealed a localized “hotspot” of critical residues on FXN, which could aid 
in designing small peptide mimics for FRDA therapeutics.  
Second, 
35
S-radiolabeling experiments indicated FXN accelerates the 
accumulation of persulfide species on NFS1 and ISCU2. The ISCU2 persulfide species 
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was established as a viable intermediate in Fe-S cluster biosynthesis by tracking the 
35
S-
radiolabel as it converts from a persulfide species to a [2Fe-2S] cluster. Additional 
mutagenic, enzymatic, and spectroscopic studies suggest conserved ISCU2 residue C104 
is critical for FXN-based activation, whereas C35, C61, and C104, are all essential for 
Fe-S cluster biosynthesis. These results lead to an activation model in which FXN 
facilitates sulfur transfer from NFS1 to ISCU2 as an initial step in Fe-S cluster 
biosynthesis and favors helix-to-coil interconversion on ISCU2.  
Third, UV-visible, circular dichroism, and Mössbauer spectroscopic studies 
indicated the SDUF complex synthesizes transient [2Fe-2S] clusters that readily transfer 
to thiol-containing acceptor molecules. Moreover, these studies revealed competing 
DTT-mediated transfer and mineralization chemistry that cause complications when 
studying the mechanism of Fe-S cluster biosynthesis.  
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NOMENCLATURE 
 
A. vinelandii                Azotobacter vinelandii 
 
CD                               circular dichroism 
 
DTT                             Dithiothreitol 
 
E. coli                          Escherichia coli 
 
FRDA                         Friedreich’s Ataxia 
 
FXN                            Frataxin (also referred to as FXN, Yfh1 (yeast frataxin), and      
                                    CyaY  (E. coli frataxin)) 
 
HEPES                        N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid 
 
IPTG                           Isopropyl β–D-thiogalactopyranoside 
 
ISCU2                         Human scaffold protein (also referred to as Isu2 (human) and IscU 
                                    (E. coli scaffold protein) 
 
NFS1                           Human cysteine desulfurase (also referred to as IscS) 
 
PAGE                          Polyacrylamide gel electrophoresis 
 
PLP                             Pyridoxal-5’-phosphate 
 
SD                               Human NFS1-ISD11 protein complex 
 
SDU                            Human NFS1-ISD11-ISCU2 protein complex 
 
SDUF                          Human NFS1-ISD11-ISCU2-FXN protein complex 
 
Tris                              Tris(hydroxymethyl) aminomethane 
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Figure 1.1. Common Fe-S clusters: (a). rhombic [2Fe-2S] and (b). cubic [4Fe-4S]. 
CHAPTER I  
INTRODUCTION 
 
Many proteins rely on cofactors in order to be functionally active enzymes. Iron-
sulfur (Fe-S) clusters are protein cofactors that are required for many critical cellular 
functions including oxidative respiration, DNA repair, and the biosynthesis of other 
cofactors.
1
 The most common role for Fe-S clusters is in electron transfer reactions, but 
additional functions such as substrate turnover, environmental sensing, and protein 
stabilization are also known. Fe-S clusters with different iron and sulfide 
stoichiometries, including common rhombic [2Fe-2S] and cubic [4Fe-4S] (Figure 1.1) 
and more specialized [3Fe-4S], [4Fe-3S], and [8Fe-7S] clusters, are fine-tuned by the 
protein environment to have the necessary chemical properties for their function.  Fe-S 
clusters are found in each of the three kingdoms of life:  Eukarya, Archaea, and  
 
 
 2 
 
 Eubacteria.
2
 Fe-S clusters are also part of more complex enzyme catalysts that are 
involved in nitrogen fixation, hydrogen production, and CO2 fixation. Remarkably, the 
Holm group and others have demonstrated that these biological Fe-S clusters can be self-
assembled in solution from iron, sulfide and appropriate sulfur-containing ligands,
3, 4
 and 
it is common to reconstitute recombinant Fe-S cluster proteins using similar conditions. 
Interestingly, the in vivo synthesis of Fe-S clusters does not use this self-assembly 
chemistry, but synthesizes Fe-S clusters using highly conserved proteins that are part of 
Fe-S cluster assembly pathways.
5-7
 The concentration of iron in yeast mitochondria is 
between 700-800 µM, which includes about 20 percent nonheme high-spin ferrous iron 
under anaerobic conditions,
8
 which would be very susceptible to redox reactions if not 
highly regulated.  The more prominent Fe-S proteins are associated with Complex I, II, 
and III for respiration of bacteria and mitochondria, photosystem I and ferredoxin for 
photosynthesis, aconitase for the citric acid cycle, nitrogenase for azotobactera, and iron 
regulatory protein 1 (IRP1) involved in iron uptake regulation in mammals.
2
  There are 
three distinct biosynthetic pathways to generate Fe-S cluster in prokaryotes.
2, 9, 10
  The 
NIF system is involved in the nitrogen fixation process that converts N2 to NH3 in 
bacteria.
11, 12
  The SUF system is involved in sulfur mobilization and is most 
predominant during oxidative stress conditions.
13
  The Iron-Sulfur Cluster (ISC) 
assembly machinery is required for the majority of Fe-S cluster proteins, and may 
perform a general “house-keeping” biosynthetic function.14  In eukaryotes, Fe-S cluster 
biosynthesis occurs in the mitochondria using a pathway with similarities to the ISC 
assembly machinery. This may be due to the mitochondria possibly originated from a 
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bacterial ancestry.
15
  This mitochondrial Fe-S assembly pathway is essential for the 
biosynthesis of Fe-S clusters found in the mitochondria, but also for Fe-S proteins 
located in the cytosol and nucleus. 
Cluster Assembly Pathway 
 The general framework for the assembly of Fe-S clusters in eukaryotes is widely 
studied, but most of the mechanistic details have not been elucidated. There are at least a 
dozen proteins involved in Fe-S cluster assembly.
2, 5, 16
  This process has been best 
studied in yeast and prokaryotes. The Fe-S biosynthetic pathway in humans is located in 
the mitochondrial matrix and the core of the iron-sulfur assembly machinery consists of 
a four protein stable complex of NFS1, ISD11, ISCU2, and frataxin (FXN), called 
SDUF.
2, 5, 16, 17
 The process is shown in Figure 1.2 for the human mitochondria and starts 
by a membrane potential (pmf)-dependent import of ferrous iron into the mitochondria 
through the metal transporters mitoferrin. The iron can be stored or delivered to ISCU2 
for cluster biosynthesis.
2, 18
  ISCU2 is the main scaffold protein involved in obtaining 
ferrous ion and inorganic sulfide to assemble a cluster and deliver it to an apo target. 
How iron is delivered to ISCU2 is unclear. Human frataxin (FXN,homolog of yeast 
Yfh1 or E. coli Cyay) has been proposed,
19, 20
 along with ISCA,
21
 to function as an iron 
donor for Fe-S cluster biosynthesis. FXN stimulates the cysteine desulfurase reaction 
and may function as an allosteric activator to regulate the Fe-S assembly complex.
22
 
FXN also appears to simulate the rate of in vitro Fe-S cluster assembly, whereas the 
bacterial homolog CyaY appears to inhibit Fe-S biosynthesis.
22-24
 NFS1 is a cysteine 
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desulfurase (homolog of bacterial IscS) catalyzes the PLP-dependent conversion of L-
cysteine to L-alanine (Figure 1.3), generates a persulfide species on a mobile loop 
cysteine, and delivers the sulfane sulfur to the Fe-S catalytic or scaffold subunit (human 
ISCU2 or bacterial IscU).
25, 26
 The cysteine desulfurase activity is often measured by 
intercepting this persulfide species using reductive thiol-cleaving reagents such as DTT 
and quantitating the generate sulfide.
27
 ISD11 is a eukaryotic-specific protein that 
appears to stabilize the cysteine desulfurase and may participate in positioning the 
mobile loop cysteine for attack of the substrate.
28-32
, whereas the ferredoxin/ferredoxin 
reductase (FDX/FDXR, yeast homolog Yah1/ Arh1) system is thought to provide 
electrons.
33, 34
 In vitro Fe-S assembly reactions often use a surrogate electron donor such 
as DTT rather than the ferredoxin/ferredoxin reductase system. Finally, chaperone and 
Fe-S carrier proteins appear to facilitate the transfer of intact Fe-S clusters from the Fe-S 
assembly complex to target proteins.
35, 36
  
 
 Figure 1.2.  A model for eukaryotic ISC assembly machinery in the mitochondrion. 
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Figure 1.3. Mechanism for the PLP- dependent catalyzed conversion from cysteine to alanine by the 
cysteine desulfurase enzyme. Reprinted with permission from Behshad, E., and Bollinger, J. (2009) 
Kinetic analysis of cysteine desulfurase CD0387 from Synechocystis sp PCC 6803: formation of the 
persulfide intermediate, Biochemistry 48, 12014-12023. Copyright © 2009 American Chemical 
Society. 
 
There is much known on the individual components of assembly proteins, but the 
mechanism for cluster formation is not as well established especially as a complex. 
There have been two possible mechanisms proposed for the Fe-S cluster assembly 
mechanisms in the SUF system (Figure 1.4).
37-39
  The proposed mechanisms are either 
an iron first or sulfur first model in assembling a [2Fe-2S] cluster. The binding constants 
for both ferrous and ferric to the Thermotoga maritima IscU and yeast FXN have been 
determined and are very weak.
40, 41
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IscS with IscU, in the absence of DTT, resulted in a persulfide-bound or polysulfide-
bound IscU.
42, 43
  The iron-first mechanism requires that the first step in cluster 
 
Figure 1.4. Proposed mechanisms for the assembly on Fe-S clusters on the ISCU2 scaffold 
protein. (A) Iron first mechanism and (B) sulfur first mechanism. Adapted with permission 
from Krebs, C., Agar, J.N., Smith, A.D., Fazzon, J., Dean, D.R., Huynh, B.H., and Johnson, 
M.K. (2001) IscA, an alternate scaffold for Fe−S cluster biosynthesis, Biochemistry 40, (46) 
14069-14080. Copyright © 2001 American Chemical Society. 
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formation is ligation of two ferrous atoms to the three conserved cysteine residues on 
ISCU2. ISCU2 has been believed to be a dimer in this reaction and may be independent 
of the complex once sulfur has been transferred from NFS1. Once the iron binds, sulfur 
is transferred from the cysteine desulfurase in the form of sulfane. This sulfane sulfur 
must be reduced by 4 electrons, to sulfide, in order to be incorporated in a [2Fe-2S] 
cluster; 2 of which are contributed from the ferrous iron atoms and 2 of which are 
proposed to come from ferredoxin.  The sulfur-first mechanism is initiated by a cysteine 
residue on the ISCU2 dimer nucleophilically attacking the persulfidic species generated 
on the catalytic loop of the cysteine desulfurase, transferring this sulfide to another 
cysteine on ISCU2 and undergoing another turn over. Ferrous iron than binds and cluster 
is formed by sequential 2-electron reduction of each sulfane sulfur atom. Sulfur has been 
shown to be incorporated on the scaffold proteins in the absence of iron, supporting a 
sulfur first mechanism.
42-44
  There is little evidence of very weak iron binding to the 
complex, but has never been shown to bind ferrous iron with cysteine ligation.
40, 41, 45
  
Neither the persulfide-bound or polysulfide-bound forms of IscU have been shown to be 
viable in cluster formation. Human ISCU2 has three conserved cysteine residues (C35, 
C61, and C104) that are involved with Fe-S cluster assembly and one non conserved 
cysteine (C96) that is presumed to be not involved in the assembly of an Fe-S cluster. 
The fourth cluster ligand is unknown but has been suggested to be H103,
46, 47
 an ISCU2 
ligand formed from ISCU2 dimerization
48
 or the mobile loop cysteine (C328) from 
NFS1.
49
  Each of these three conserved cysteine residues on the scaffold protein has 
been implicated in acting as the sulfur acceptor residue during the sulfur transfer 
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reaction. Electrospray-ionization mass spectrometry was used to show that the 
Azotobacter vinelandii cysteine desulfurase could deliver a persulfide or polysulfide 
species to the scaffold protein even if each of three cysteine residues were mutated to 
alanine resulting in a covalent disulfide bridge between C37 (C35 in human numbering) 
and the catalytic cysteine of the cysteine desulfurase.
50
   The sulfur-first mechanism 
seems to be the most favorable, but whether a particular cysteine residue on ISCU2 
accepts the sulfur atom from NFS1 or multiple cysteine residues, is still debatable. The 
E. coli scaffold protein shows an essential role for C106 (C104 in human numbering) in 
accepting the persulfide sulfur from the cysteine desulfurase enzyme.
44
  The equivalent 
sulfur transfer experiments have not yet been performed on a eukaryotic system. Most 
experiments are also performed as individual components and have not in the context of 
a complex. The pathway of both iron and sulfur throughout the Fe-S cluster biosynthesis 
has never been shown to be incorporated into an assembled Fe-S cluster and transferred 
to an apo target.  
The prokaryotic scaffold protein IscU combines sulfur generated from cysteine 
by the cysteine desulfurase, iron, and electrons to synthesize [2Fe-2S] and [4Fe-4S] 
clusters. Currently, no intermediates in generating [2Fe-2S] clusters are established in 
the biosynthetic system or self-assembly process, but some details of the conversion of 
[2Fe-2S] clusters to [4Fe-4S] clusters are known. Inorganic biomimetic chemistry 
revealed that [4Fe-4S] clusters can be formed by reductively coupling two [2Fe-2S] 
clusters,
3
 whereas studies of the oxygen sensor protein FNR reveal the conversion of 
persulfide ligated [2Fe-2S] cluster to cysteine ligated [4Fe-4S] cluster upon the addition 
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of iron.
51
 In key early studies on biosynthetic systems, Agar et al. demonstrated that 
[2Fe-2S] clusters can be assembled on IscU in an IscS mediated process,
52
 and Foster et 
al. showed that the human ISCU2 D37A variant contains a stable [2Fe-2S] cluster.
53
 
IscU binds clusters with three conserved cysteines,
50
 with experimental support for a 
semi-conserved histidine,
46, 54
 aspartic acid,
55
 and a cysteine from another molecule
56, 57
 
as the fourth ligand. In a remarkable study, the Huynh, Dean, and Johnson groups 
demonstrated reductive coupling chemistry on an IscU dimeric species with the 
sequential formation of a single [2Fe-2S] cluster, a second [2Fe-2S] cluster, and then 
conversion of these [2Fe-2S] clusters to form one [4Fe-4S] cluster per IscU dimer.
48
 
This reductive coupling chemistry appears to occur at an IscU dimeric interface with 
each monomer contributing one [2Fe-2S] cluster. 
An Fe-S assembly complex appears to be responsible for the synthesis of [2Fe-
2S] and possibly [4Fe-4S] clusters for the ISC pathway. A protein complex between 
bacterial IscS and IscU has been demonstrated in solution,
42, 58
 and crystal structures 
with
56
 and without
59
 a [2Fe-2S] cluster provide details of the protein-protein interactions 
and cluster environment. An apparent key to obtaining a crystal structure of the bound 
[2Fe-2S] cluster was the incorporation of the D35A variant,
56
 which was previously 
shown to stabilize the cluster bound state and/or inhibit cluster transfer.
53, 60, 61
 
Interestingly, Mössbauer spectroscopic studies suggest the addition of L-cysteine, ferrous 
iron, and DTT to the bacterial and mammalian Fe-S assembly complexes results in the 
formation of [2Fe-2S] and [4Fe-4S] cluster species.
62, 63
 These results suggest at least 
two models. In the first model, IscU subunits dissociate after building [2Fe-2S] clusters, 
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and this dissociated [2Fe-2S]-bound IscU undergoes reductive coupling chemistry to 
generate [4Fe-4S] clusters. In the second model, [2Fe-2S] clusters synthesized on the Fe-
S assembly complex transform to [4Fe-4S] clusters through chemistry that may resemble 
the [2Fe-2S]  [4Fe-4S] conversion for FNR.51 The first model is supported by the 
ability of the scaffold protein to undergo reductive coupling chemistry,
48, 64
 whereas the 
second model is suggested by recent studies of a eukaryotic Fe-S assembly complex.
62
 
Human Fe-S Cluster Assembly 
Human FXN has been shown to stimulate NFS1 activity (Figure 1.5A).  The 
activity and Michaelis- Menten kinetics was measured by using the methylene blue 
assay to quantify the amount of sulfide produced from L-cysteine conversion to L-
alanine and a persulfide species, which is then released by dithiothreitol (DTT). The 
reaction is quenched by the addition of N,N-dimethyl-p-phenylenediamine (DMPD) and 
FeCl3 in 1.2 M HCl (Figure 1.6).
65
  Methylene blue is measured by measuring the 
absorbance at 670 nm to determine the sulfide concentration. Ferrous iron has been 
shown to stimulate NFS1 activity (Figure 1.5B).
17
  Ferrous iron appears to further 
stimulate NFS1 activity
17
 and is unclear if this iron is incorporated in a cluster or could 
be involved in stabilizing the complex. Ferrous may also stabilize interactions between 
FXN and ISCU2 in the absence of NFS1/ISD11.
66
  The iron may also be bound to 
ISCU2, presumably to the surface cysteine residues or to the carboxylate-rich region of 
FXN.
67
  The crystal structures of bacterial IscS (homolog of NFS1)
59, 68
, bacterial 
IscU/IscS complex (Figure 1.7A),
69
 bacterial IscU (Figure 1.7B, homolog of ISCU2)
47
, 
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Figure 1.5. Frataxin and ferrous iron stimulates cysteine desulfurase activity. (A) Rates of SD 
cysteine desulfurase activity were determined by measuring sulfide production in the presence and 
absence of 3 equivalents of ISCU2 and/or FXN, and either 0 or 10 equivalents of ferrous iron. (B) 
Rates of sulfide production were determined for SD in the presence of 3 equivalents of ISCU2 and 
FXN, and increasing amounts of ferrous iron. Reprinted with permission from Tsai, C., and 
Barondeau, D. P. (2010) Human frataxin is an allosteric switch that activates the Fe-S cluster 
biosynthetic complex, Biochemistry 49, 9132–9139. Copyright © 2010 American Chemical Society. 
 
  
 
and human frataxin (Figure 1.7C) have been previously determined, which may provide 
structural insight for the human NFS1 and NFS1-ISCU2 complex.
70, 71
  There have also 
been simulations where Cyay (homolog of FXN) may bind the IscS-IscU complex, 
which can help generate a model for an NFS1-ISCU2-FXN complex.
69
 This model could 
help in elucidating the mechanism for Fe-S cluster biosynthesis.   
 
Figure 1.6. Reaction mechanism for methylene blue formation. 
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Figure 1.7. Crystal structure of E. coli IscS-IscU complex (A, PDB code 3LVL), IscU (B, PDB code 
3LVL), and human FXN (C, PDB code 1EKG). In (A) the IscS is in cyan and IscU is in green. In (B) 
the IscU conserved cysteine residues are highlighted in magenta. In (C) FXN carboxylic patch is 
highlighted in cyan. 
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Fe-S Cluster and Health 
Deficiencies in the iron-sulfur cluster biosynthetic pathway have been implicated 
in several human diseases.
16
  Friedreich’s Ataxias is the most studied disease and is an 
autosomal, recessive neurodegenerative disorder caused by the deficiency of frataxin.
72
  
Frataxin is widely suggested to be a chaperone for delivering iron directly to Isu2. 
Frataxin is well conserved among prokaryotes and eukaryotes. Cellular depletion of 
frataxin due to lower protein expression or loss of frataxin’s functional properties leads 
to loss of Fe-S protein activities, mitochondrial iron accumulation, and oxidative 
damage.
73
  Mitochondria dysfunction has also been implicated in several human 
diseases. Nerve cells in the brain and muscles require a great deal of energy, and thus 
appear to be particularly damaged by mitochondrial dysfunction. Mitochondrial 
dysfunctions can result in myoclonus epilepsy, strokes, heart failure, muscle weakness, 
exercise intolerance, dementia, deafness, and blindness. Defects in the Fe-S cluster 
pathway are associated with cardiomyopathy, neurodegenerative ataxia, and can even 
contribute to the development of cancer and aging.
74
 The prognosis for these disorders 
ranges in severity from progressive weakness to death.
16, 75
 
Here we build upon these observation and present mechanistic details on the 
assembly of an Fe-S cluster on the human SDUF complex. We designed experiments 
that support a model in which FXN stabilizes a conformation that both accelerates 
persulfide formation on NFS1 and also interprotein sulfur transfer from NFS1. We need 
to determine residues on FXN that are important for this activation and what residues 
affect binding. To further investigate the mechanism of Fe-S cluster biosynthesis, we 
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will first need to identify the persulfide accepting cysteine residue on ISCU2 from 
NFS1, establish that the persulfide formed on ISCU2 in the sulfur transfer reaction is 
viable in a subsequent Fe-S synthesis reaction, determine the type of Fe-S cluster the 
human SDUF complex synthesizes, and the transfer to apo targets. 
 15 
 
CHAPTER II 
HUMAN FRATAXIN ACTIVATES FE-S CLUSTER BIOSYNTHESIS BY 
FACILITATING SULFUR TRANSFER CHEMISTRY 
 
Introduction 
Sulfur is a critical element for all life forms and is found in a variety of protein 
cofactors including molybdopterins, lipoic acid, thiamin, biotin, and iron-sulfur (Fe-S) 
clusters. Even though the functions of these cofactors are well understood, mechanistic 
details are just emerging for how sulfur is incorporated into these biomolecules.
76, 77
 A 
common early step for these pathways is the cysteine desulfurase catalyzed degradation 
of cysteine to alanine and the generation of a protein-bound persulfide species. This 
activated sulfur is reductively cleaved by distinct acceptor proteins for the biosynthesis 
of sulfur-containing cofactors and modification of tRNA.
76
 Redox agents such as 
cysteine and DTT (in vitro) can also release the terminal sulfur of the persulfide in an 
often rate-determining step for the cysteine desulfurase that produces hydrogen 
sulfide.
25, 27
    
Bacteria, archaea, and eukaryotic organelles use one or more of the ISC, NIF, 
and SUF systems for the biosynthesis of Fe-S clusters. In the ISC assembly system of 
Escherichia coli, the cysteine desulfurase IscS uses a PLP cofactor to assist in cleaving 
the sulfur-carbon bond of L-cysteine and generating a persulfide intermediate on residue 
C328.
78
 The scaffold protein IscU combines the sulfane sulfur generated by IscS, ferrous 
iron, and electrons to synthesize Fe-S clusters. Crystal structures of the bacterial IscS- 
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IscU complex have been determined with
56
 and without
59
 a [2Fe-2S] cluster bound. The 
crystal structure of the E. coli complex revealed that IscS C328 (equivalent to C381 on 
human NFS1) is positioned on a highly flexible loop and can potentially traverse the ~30 
Å distance between an IscS substrate-PLP adduct and conserved cysteine residues of 
IscU. Although the functional significance for sulfur transfer is unclear, IscS C328 can 
form disulfide crosslinks with conserved IscU residues C37
50
 and C63
58
, consistent with 
the suggestion based on the IscS-IscU crystal structure
59
 that these residues on IscU 
could function as sulfur acceptor residues during Fe-S cluster biosynthesis. The third 
conserved cysteine, C106, is somewhat buried on the C-terminal -helix of IscU.  
Research conducted on the bacterial ISC Fe-S assembly system has yet to 
identify intermediates on the Fe-S assembly complex during cluster biosynthesis or 
establish if sulfur can be viably transferred from the cysteine desulfurase to the scaffold 
protein before, after, or simultaneous with iron incorporation. Radiolabeling and mass 
spectrometry experiments for the ISC system have been used to track interprotein 
persulfide-based sulfur transfer from IscS to IscU.
42, 43, 50
 However, the persulfide (or 
polysulfide) species that were bound to IscU did not appear to be viable in Fe-S cluster 
formation. Kinetic data demonstrated that E. coli IscU variants C37S and C106S, but not 
C63S, stimulated sulfide production by IscS,
58
 leading to the conclusion that IscU C63 
assists in the rate-limiting cleavage of the IscS C328 persulfide species. However, 
subsequent kinetic experiments failed to observe any IscU-based stimulation of sulfide 
production by IscS.
24, 63
 In contrast, recent experiments monitoring iron-sulfur cluster 
reconstitution on E. coli ferredoxin hinted that IscU residue C106, and not C37 or C63, 
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has an role in sulfur transfer from IscS to IscU.
79
 These experiments have led to 
proposals that C63
58
, C106
79
, either C37 or C63
69
, or any of the three conserved cysteine 
residues on IscU
50
 can function as the acceptor in the sulfur transfer reaction for the 
prokaryotic ISC system. Differences in binding affinities for IscU variants to IscS, the 
facile reactivity of persulfide species with thiol containing molecules, and differences in 
experimental design such as bypassing IscS (chemical reconstitution), using catalytic 
amounts of IscS, or using conditions consistent with the IscS-IscU complex, may 
contribute to these different conclusions.  
In eukaryotes, recent evidence suggests Fe-S biosynthesis is catalyzed by an 
assembly complex that exists in at least two forms: the mostly inactive SDU complex, 
which contains the subunits NFS1, ISD11, and ISCU2, and the activated SDUF 
complex, which contains the subunits NFS1, ISD11, ISCU2, and frataxin (FXN).
22, 80
 In 
humans, the 94 kDa homodimeric cysteine desulfurase NFS1 (homolog of IscS) 
provides sulfur for Fe-S cluster biosynthesis.
25, 81
 ISD11 is a eukaryotic-specific protein 
that interacts, stabilizes, and may activate NFS1.
29, 30, 82-85
 Cluster assembly is templated 
by the scaffold protein ISCU2 (homolog of IscU), whereas FXN stimulates the cysteine 
desulfurase and Fe-S cluster assembly reactions.
22, 62, 86, 87
 Defects in FXN are linked to 
the neurodegenerative disease Friedreich’s ataxia (FRDA),88, 89 and FXN variants 
encoded by FRDA missense mutations have compromised ability to bind and activate 
the Fe-S assembly complex.
86, 87
 
The ability of FXN to enhance the cysteine desulfurase and Fe-S assembly 
activities implies that it is involved in sulfur mobilization and/or transfer chemistry from 
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the cysteine desulfurase NFS1 to the scaffold protein ISCU2. A 
35
S-radiolabeling 
experiment using Saccharomyces cerevisiae mitochondria revealed a NFS1 persulfide 
species under iron depleted conditions and radiolabeled ferredoxin under iron repleted 
conditions.
85
 However, few details are known about the eukaryotic sulfur hand-off 
mechanism from NFS1 to ISCU2 (see Figure 2.1 for a model of the human NFS1-ISCU2 
complex) and the role of FXN in this process. One of the advantages of this 
experimental system compared to the bacterial ISC systems is the dramatic rate 
enhancement of the cysteine desulfurase reaction upon FXN binding. Here we build 
upon this observation and present experiments that support a model in which FXN 
stabilizes a conformation that both accelerates persulfide formation on NFS1 and also 
interprotein sulfur transfer from NFS1 to residue C104 on ISCU2 (equivalent to E. coli 
C106) as an early step in Fe-S cluster biosynthesis. Furthermore, we establish that the 
persulfide formed on ISCU2 in the sulfur transfer reaction is viable in a subsequent Fe-S 
synthesis reaction, consistent with a sulfur-first mechanism. 
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Experimental Procedures 
Protein Expression and Purification 
Eight human ISCU2 cysteine variants (C96S, C35A, C35S, C61A, C61S, 
C104A, C104S, and C35A/C61A) were created by QuikChange site-directed 
mutagenesis (Stratagene) using a pET11a-ISCU2 plasmid template,
22
 and the mutation 
sites were confirmed by DNA sequencing (Gene Technologies Lab at TAMU). The 
resulting plasmids containing ISCU2 with the desired mutations were transformed into 
BL21(DE3) cells and grown at 37 ºC until reaching an OD600 of 0.6. Protein expression 
was induced at 16 ºC with 0.5 mM IPTG and the cells were harvested 16 hours later. The 
ISCU2 variants along with human NFS1-ISD11 (SD) and FXN were purified as 
 
Figure 2.1. Human NFS1-ISCU2 complex modeled from the crystal structure of the analogous 
IscS-IscU complex (PDB 3LVL).  NFS1 subunits are shown in green and cyan, whereas 
ISCU2 is displayed in magenta. 
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previously described
22
 with the exception of adding 10% glycerol to the buffers for the 
C61A and C35A/C61A mutants.  
Human ferredoxin (FDX, gift from John Markley)
90
 was transformed into E. coli 
BL21 (DE3) cells and grown at 37 ºC until reaching an OD600 of 0.6. Expression was 
induced for 16 hours with 0.4 mM IPTG, 1 mM cysteine, and 0.1 mg/mL ferric 
ammonium citrate. Cells were lysed by sonication and the supernatant was loaded onto 
an anion exchange column (26/20 POROS 50HQ, Applied Biosystems) and eluted with 
a linear gradient from 0 to 1000 mM NaCl in 50 mM Tris pH 7.5. Fractions containing 
FDX were further purified on a Sephacryl S100 (26/60, GE Healthcare) size exclusion 
column equilibrated in 50 mM Tris, pH 7.4, 50 mM NaCl. Apo FDX was prepared by 
precipitating the purified FDX with a 10% trichloroacetic acid solution containing 10 
mM DTT on ice for 10 minutes, after which the sample was pelleted by centrifugation.
91
  
The protein pellet was rinsed twice with water and then re-suspended anaerobically in 
Buffer A (50 mM Tris pH 8.0, 250 mM NaCl).
91
 Protein concentration was determined 
by the Bradford method for reconstituted FDX, and using an extinction coefficient ε280 = 
2980 M
-1
cm
-1
 for apo FDX. 
SDS-PAGE Analysis of Sulfur Transfer 
Reaction mixtures (30 μL) for monitoring sulfur transfer included 3 μM SD, 9 to 
120 μM ISCU2, Buffer A and either 0 or 9 μM FXN. A similar experiment was 
performed in which 9 μM of the FRDA FXN variants N146K, Q148R, I154F, W155R, 
and R165C, which were purified as previously described,
86, 87
 were substituted for native 
FXN. Samples were incubated in the glovebox for 10 minutes prior to the addition of 
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100 M “hot” L-cysteine, prepared by adding 50 Ci/mmol 35S-cysteine (American 
Radiolabeled Chemicals Inc.) to a 1 mM “cold” cysteine stock solution. After a 2-minute 
incubation at 37 °C, reactions were terminated by centrifugation through a Micro Bio-
Spin P-6 gel filtration column (Bio-Rad). The spin column flow through was combined 
with non-reducing SDS-PAGE sample loading buffer and then loaded on a non-reducing 
14% SDS-PAGE gel. The gel was dried onto chromatography paper in a gel-drying oven 
at 60 °C under vacuum before a 12-hour exposure to a phosphor screen. 
35
S label 
incorporation was visualized using a Phosphorimager (Typhoon Trio, GE Healthcare).    
Tracking Sulfur from L-cysteine through the SDUF Complex to a Fe-S Cluster on FDX 
 To test if the 
35
S radiolabel from the substrate L-cysteine can be transferred to 
ISCU2 and then to the [2Fe-2S] cluster of FDX, a sample was prepared that contained 
80 μM SD, 240 μM ISCU2, 240 μM FXN, Buffer A in a total volume of 400 μL. The 
reaction was initiated with the addition of 20 Ci/mmol L-[
35
S]-cysteine and allowed to 
proceed for 40 minutes anaerobically at 10 ºC. The sample was then loaded onto a 1 mL 
HisTrap HP column (GE Healthcare) equilibrated in 50 mM Tris pH 7.5, 200 mM NaCl, 
and 5 mM imidazole, and eluted with a linear gradient from 5 to 500 mM imidazole. To 
evaluate 
35
S-persulfide incorporation, 30 μL of each fraction from the 1 mL HisTrap HP 
column was centrifuged through a Micro Bio-Spin P-6 gel filtration column (Bio-Rad) 
and combined with 8 μL non-reducing SDS-gel loading dye and loaded on a 14% SDS-
PAGE gel that was dried, exposed, and imaged as described above. Fractions containing 
labeled NFS1 and ISCU2 were concentrated to 70 μL, of which 20 μL was analyzed for 
SDUF complex formation using a 6.5% native gel.
22
 The remaining 50 μL of 
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radiolabeled SDUF complex was incubated anaerobically at 10 ºC with 600 μM 
Fe(NH4)2(SO4)2, 160 μM L-cysteine, and 1 mM DTT for 1 hour. After incubation, the 
excess reaction components were removed using a Micro Bio-Spin P-6 column that was 
buffer exchanged into Buffer A. The material that flowed through the Bio-Spin P-6 
column was incubated with 200 μM apo FDX anaerobically 10 ºC for 1 hour. The 
sample was then loaded and eluted from a 1 mL HisTrap HP column as described above, 
except that absorbance was monitored at 405 nm rather than 280 nm. The flow-through 
fractions corresponding to non His-tagged FDX were concentrated to 20 μL before 
loading onto a non-reducing 6.5% native gel. Radiolabel incorporation was analyzed 
with a phosphorimager as described above. 
ISCU2 Binding to and Stimulation of Fe-S Assembly Complex   
Protein titrations, monitored by cysteine desulfurase activity measurements, were 
performed to determine the number of ISCU2 and FXN equivalents to overcome any 
loss of binding affinity for the SDUF complex due to ISCU2 mutations. For the titration 
of ISCU2 variants, the reaction mixtures were initiated with 100 M L-cysteine and 
included 0.5 μM SD, 2 mM DTT, 10 μM PLP, and Buffer A. Sulfide production was 
measured using a previously described methylene blue formation assay.
22
 The number of 
equivalents required for each ISCU2 variant (calculated based on the SD concentration) 
to no longer change or saturate the cysteine desulfurase activities was determined to be 3 
(native ISCU2, C35A, and C104A), 30 (C96S), 20 (C35S), 80 (C61A and C61S), 10 
(C104S), and 200 (C35A/C61A). Once the saturating amounts of the ISCU2 variants 
were determined, additional titrations were performed to determine the amount of FXN 
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needed to maximize the activity of the respective SDU complex. The number of 
equivalents of FXN was determined to be 3 (native ISCU2), 5 (C96S), 80 (C35A and 
C35S), 200 (C61A and C61S), 30 (C104A), 50 (C104S), and 400 (C35A/C61A). After 
determining the number of equivalents of FXN to maximize the cysteine desulfurase 
activity, additional equivalents of ISCU2 variants were added and the cysteine 
desulfurase activity was measured. The cysteine desulfurase activity did not further 
increase confirming saturation of ISCU2 subunits in the SDUF complex.  
Michaelis-Menten Parameters for ISCU2 Variant Complexes   
Reaction mixtures included 0.5 μM SD, 2 mM DTT, 10 μM PLP, Buffer A, and 
the saturating amount of ISCU2 variant and FXN (determined above) in the presence or 
absence of 5 μM Fe(NH4)2(SO4)2. The samples were incubated in a glovebox (mBraun; 
~12 °C and < 1 ppm oxygen) for 30 min before initiation of the reaction with L-cysteine. 
The L-cysteine concentration ranges used were 12.5-400 μM for native, C35A, C35S 
C61A, C61S, and C96S variants, and 12.5-1000 μM for the C104A, C104S, and 
C35A/C61A variants. Reaction rates as a function of L-cysteine concentration were fit to 
the Michaelis-Menten equation using KaleidaGraph software (Synergy Software).  
Cysteine Desulfurase and Fe-S Assembly Activities for ISCU2 Variant Complexes   
The cysteine desulfurase activity for the different SDU complexes were 
determined in triplicate using a physiological L-cysteine concentration of 0.1 mM with 
0.5 μM SD, 2 mM DTT, 10 μM PLP, Buffer A, and saturated amounts of the different 
ISCU2 variants. Similar experiments were also performed with saturating FXN in the 
absence or presence of 5 μM Fe(NH4)2(SO4)2. The Fe-S cluster assembly activity was 
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measured using a standard UV-visible assay
22
 and also with a circular dichroism (CD) 
assay. For the UV-visible assay the reaction mixture contained 8 μM of SD, 5 mM DTT, 
200 μM Fe(NH4)2(SO4)2, 100 μM L-cysteine, and Buffer A in a total volume of 0.2 mL. 
In addition, saturating amounts of the ISCU2 variants with or without saturating amounts 
of FXN were added to the assay mixture. The ISCU2 variants were incubated for 1 hour 
with 5 mM DTT in an anaerobic glovebox before addition of the remaining reaction 
components in an anaerobic cuvette. The reaction was initiated in an anaerobic cuvette 
by injecting L-cysteine to a final concentration of 100 μM with a gas-tight syringe. Fe-S 
cluster formation was monitored at 456 nm at room temperature for 3000 seconds at 20 
°C and then fit as first order kinetics using KaleidaGraph software. Anaerobic CD 
monitored Fe-S cluster assembly assays mixtures contained 10 μM of SD, saturating 
amounts of ISCU2 variants and FXN, 200 μM Fe(NH4)2(SO4)2, 1 mM L-cysteine, and 
Buffer A in a total volume of 0.4 mL. The reactions were initiated with injection of 1 
mM L-cysteine and the ellipticity was measured over the wavelength range 300-600 nm 
for 60 minutes at 20
 
°C using a CD spectrometer (Chirascan
TM
). 
Results 
FXN Increases Sulfur Incorporation on NFS1 and ISCU2   
Previously, human FXN binding to the SDU complex was shown to dramatically 
increase the cysteine desulfurase and Fe-S cluster biosynthesis activities for the 
assembly complex.
22
 To test the hypothesis that FXN activation functions at the step of 
persulfide species formation on ISCU2, we monitored the transfer of radioactive sulfur 
from a L-[
35
S]-cysteine substrate. In this experiment, increasing concentrations of 
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ISCU2 were added to the SD complex in either the presence or absence of FXN. The 
samples were incubated for two minutes with the radiolabeled substrate, excess label 
was removed anaerobically with a desalting column, and then the individual subunits of 
the SDU or SDUF complexes were analyzed with non-reducing SDS-PAGE (Figure 
2.2). Radioactivity associated with NFS1 and ISCU2 under denaturing conditions 
indicate formation of covalent adducts (likely a persulfide species; see Discussion). 
Next, the ability of FRDA FXN variants were tested using the same radiolabeling 
procedure. Samples of the SDU and SDUF complexes were compared to SDUF samples 
containing the N146K, Q148R, I154F, W155R, and R165C FRDA variants (Figure 2.3). 
The FRDA variants qualitatively resulted in lower amounts of label incorporation on 
both NFS1 and ISCU2 under this set of experimental conditions. Together these results 
indicated a FXN-dependent increase in the radiolabel band intensity, which we have 
assigned as a persulfide species, associated with both NFS1 and ISCU2, and that this 
increase in label incorporation is diminished for FRDA variants. Interestingly, the 
R165C FXN variant was also labeled in this experiment. As this FXN variant labeling is 
probably a nonphysiological event, it is important to establish that the 
35
S-label that is 
incorporated onto ISCU2 is consistent with a physiological event by testing if persulfide-
bound ISCU2 species are viable in forming Fe-S clusters. 
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Persulfide-bound Intermediate in Human Fe-S Cluster Biosynthesis  
Here, sulfur transfer from NFS1 to ISCU2 and subsequent incorporation into an 
Fe-S cluster was investigated using the radiolabeled L-cysteine substrate and tracking 
the 
35
S progression from the ISCU2 subunit of the SDUF complex to human FDX. 
Combining SD with three equivalents of both ISCU2 and FXN generated the SDUF 
complex. The SDUF complex was reacted with L-[
35
S]-cysteine (see Methods) and 
applied to a HisTrap column in which non-complexed ISCU2 and/or FXN flowed 
through the column and proteins associated with 6X-His-NFS1 bound and were eluted 
with imidazole (Figure 2.4). The radioactivity was correlated with fractions that bound 
the column (fractions 11-13) and specifically was associated with both NFS1 and ISCU2  
  
 
Figure 2.2. FXN enhances sulfur accumulation on NFS1 and ISCU2. Radiolabeled sulfur 
incorporation from 
35
S-L-cysteine substrate on NFS1 with subsequent transfer to ISCU2 was 
monitored by non-reducing SDS-PAGE separation coupled to phosphor imaging. Samples of SD and 3 
to 40 equivalents of ISCU2 without FXN and with FXN were incubated for 2 minutes with 
35
S-
cysteine and analyzed by SDS-PAGE. The first three lanes are SD, ISCU2, or FXN controls that were 
incubated for 2 minutes with 
35
S-cysteine. 
 27 
 
 
Figure 2.3. FRDA variants decrease the rate of sulfur accumulation on NFS1 and ISCU2. 3 
equivalents of ISCU2 and 3 equivalents of FXN variants (native FXN, N146K, Q148R, I154F, 
W155R, and R165C) were used in a radiolabeling experiment using conditions similar to Figure 2. 
* This experiment was performed by Dr. Jennifer Bridwell-Rabb 
 
 
 
(Figure 2.4B). Very little radioactivity was associated with the non-complexed flow 
through fractions. A non-reducing native gel showed that the radioactivity was 
linked to a slower migrating band (Figure 2.4C) that had been previously shown
22
 to be 
associated with the SDUF complex (Figure 2.5). Next, this 
35
S-labeled SDUF complex 
(fractions 11-13 from the HisTrap column) was incubated with ferrous iron, non-
radioactive L-cysteine, and DTT, which are conditions consistent with synthesizing Fe-S 
clusters (see below). A desalting column was used to remove the unreacted substrates, 
the sample was incubated with apo-FDX and loaded onto a HisTrap column, and the 
fractions were analyzed using a 405 nm filter. Fractions 2 and 3 from the flow through 
exhibited absorbance at 405 nm (Figure 2.4D), consistent with an Fe-S cluster, and a 
similar retention time on a native gel as a FDX standard (Figure 2.4E, top). The NFS1  
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PLP cofactor also absorbs at 405 nm, as seen in fractions 11-13. Moreover, 
phosphorimaging analysis revealed the 
35
S-label was associated with the same fractions 
and that this label was not released upon the addition of DTT, again consistent with a Fe-
S cluster and not a persulfide species bound to FDX (Figure 2.4E, bottom). Thus, these  
 
Figure 2.4. 
35
S-radiolabel tracking from a cysteine substrate to a Fe-S cluster on FDX. The SDUF 
complex was reacted (see Methods) with L-[
35
S]-cysteine, and (A) fractionated with a HisTrap 
column. (B) Fractions were analyzed for protein (top) and radioactivity (bottom) with non-
reducing 14% SDS-PAGE, and (C) the fractions 11-13 corresponding to 
35
S-SDUF were combined 
and analyzed for protein (top) and radioactivity (bottom) with non-reducing 6.5% Native-PAGE. 
35
S-SDUF was then reacted with iron (see Methods), and (D) fractionated on a second HisTrap 
column. (E) Fractions 2-3 from (D) were combined and analyzed with native PAGE in the absence 
(labeled 1) and presence (labeled 2) of DTT. Standards SD, ISCU2, FXN, FDX, SDU were 
included for the native gels, proteins were stained using Coomassie blue, and radioactivity was 
detected using a Phosphorimager. Absorbance (blue) at 280 (panel A) or 405 (panel D) nm was 
overlaid with a 5-500 mM imidazole gradient (pink). 
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data support a persulfide-bound ISCU2 species being a viable intermediate and the 
terminal sulfur of the persulfide species being converted into the inorganic sulfide of a 
Fe-S cluster during cofactor biosynthesis. 
ISCU2 C104 Variants Disrupt Cysteine Desulfurase Activation by FXN   
Here we constructed human ISCU2 variants of the non-conserved cysteine (C96), 
the conserved cysteine residues (C35, C61, C104), or combinations of the conserved 
cysteine residues to test the roles of these residues in the sulfur transfer and Fe-S cluster 
assembly reactions. The conserved cysteine residues were mutated to both serine, which 
is the best structural mimic of cysteine, and alanine, which has no ability to function in 
 
Figure 2.5. Native gel showing complex formation for ISCU2 variants. Non-reducing 6.5% 
Native-PAGE analysis of protein includes 180 µM ISCU2, 250 uM C35A, 250 µM C61A, 350 
µM C104A, 150 µM FXN, 40 µM SD, and SDU (40 µM SD and 120 µM FXN) standards.  The 
variant complexes contained 40 µM SD, 120 µM FXN, and 120 µM ISCU2, C35A, C61A, and 
C104A, respectively. All samples contained 10 mM DTT, 100 mM HEPES, pH 7.5, 50 mM 
NaCl, and 10 mM TCEP. The position of the slower migrating band that corresponds to a SDUF 
complex and FXN were indicated on the right side of the figure. * This experiment was performed 
by Dr. Chi-Lin Tsai. 
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sulfur transfer or cluster ligation. As these surface mutations could affect the binding 
affinity of ISCU2 and/or FXN to the SD complex, we determined the ability of these 
ISCU2 variants to form the SDUF complex using native gel analysis, and the relative 
binding affinities by monitoring changes in the cysteine desulfurase activity as a 
function of concentrations of ISCU2 and FXN (see Methods). Native gel analysis 
revealed that the SDUC35AF, SDUC61AF, and SDUC104F complexes formed the slower 
migrating band that is characteristic of the four-protein SDUF complex (Figure 2.5).
22
  
Interestingly, the slower migrating band is less defined for the C61S variant, suggesting 
this variant may affect binding more than the other mutants. This conclusion is 
supported by the kinetic titration experiments. Here the number of equivalents of ISCU2 
and FXN that were required to exhibit saturation in the cysteine desulfurase reaction 
were determined (Table 2.1). In particular, C61 variants appeared to have the largest 
effect on binding, whereas mutations affecting C104 and the non-conserved C96 had 
modest binding effects. Saturating amounts of ISCU2 and FXN were used for all 
subsequent studies to remove complications from changes in binding affinity due to the 
incorporated ISCU2 mutations. 
Next, we determined that assembly complexes that include C104 variants 
behaved differently than the other cysteine variants in sulfur transfer chemistry. In the 
absence of FXN, all of the SDU variant complexes exhibited typical unactivated cysteine 
desulfurase activities that were similar to the native SDU complex (Figure 2.6A). In the 
presence of FXN, the SDUC96SF, SDUC35AF, SDUC35SF, and SDUC61AF complexes 
exhibited kcat values similar (9.4 – 11.1 min
-1
) to the 10.7 min
-1
 for the native SDUF 
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complex (Table 2.2). The kcat for the SDUC61SF (5.9 min
-1
) and SDUC35A/C61AF (6.4 min
-
1
) complexes were slightly compromised compared to the native SDUF complex, 
whereas complexes for the C104A (0.9 min
-1
) and C104S variants (2.7 min
-1
) were more 
similar to samples that lacked FXN (0.8 min
-1
). Moreover, all SDUF variant complexes, 
except those that include mutation of C104, exhibit characteristic iron-based stimulation 
of the cysteine desulfurase activity (Figure 2.6B), which was previously shown to be 
associated with FXN binding.
22
 These data indicated that mutations at position C104, but 
not the other cysteine residues, were compromised in their FXN-associated stimulation 
of the cysteine desulfurase reaction and suggested a link between residue C104 and FXN 
activation. 
 
 
Figure 2.6. Cysteine desulfurase activity for Fe-S assembly complexes containing different 
ISCU2 variants. (A) Cysteine desulfurase activity for SDU complexes with different ISCU2 
variants compared to the native SDUF complex.  The double mutant is the ISCU2 variant 
C35A/C61A. (B) Cysteine desulfurase activity for the SDUF complexes with saturating amounts 
of FXN and ISCU2 variant in the presence and absence of 10 equivalents of Fe
2+
. Error bars in A 
and B are for three independent measurements. All assays performed with 100 M L-cysteine.  
* This experiment was performed by Dr. Jennifer Bridwell-Rabb 
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Table 2.1.  Kinetic Data for ISCU2 Variant Complexes without Fe
2+
 
Complex ISCU2 equiv FXN equiv kcat (min
-1
) KM
L-cys
(mM) kcat/KM(M
-1
s
-1
) 
SDU 3 NA 0.8 ± 0.1 0.052 ± 0.014 260 ± 70 
SDUF
 
 3 3 7.8 ± 0.4 0.015 ± 0.005 8500 ± 3100 
SDUC96SF 30 5 8.2 ± 0.3 0.018 ± 0.004 7700 ± 1600 
SDUC35AF 3 80 8.7 ± 0.5 0.024 ± 0.005 6100 ± 1400 
SDUC35SF 20 80 5.9 ± 0.3 0.014 ± 0.003 7200 ± 1700 
SDUC61AF 80 200 4.2 ± 0.1 0.010 ± 0.001 6700 ± 930 
SDUC61SF 80 200 3.0 ± 0.2 0.018 ± 0.005 2800 ± 670 
SDUC104AF 3 30 1.0 ± 0.1 0.033 ± 0.001 500 ± 170 
SDUC104SF 10 50 3.2 ± 0.1 0.014 ± 0.002 4000 ± 680 
SDUC35A/C61AF 200 400 4.5 ± 0.3 0.021 ± 0.007 3600 ± 1200 
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 Table 2.2.  Kinetic Data for ISCU2 Variant Complexes with 10 Equivalents of Fe
2+
 
Complex kcat (min
-1
) KM
L-cys
(mM) kcat/KM(M
-1
s
-1
) 
SDU     0.8 ± 0.1 0.052 ± 0.014 260 ± 70 
SDUF 10.7 ± 0.8 0.019 ± 0.006 9200 ± 3000 
SDUC96SF 9.9 ± 0.9 0.021 ± 0.008 8000 ± 3200 
SDUC35AF 11.1 ± 0.6 0.018 ± 0.005 10000 ± 2600 
SDUC35SF 9.4 ± 0.5 0.020 ± 0.005 7700 ± 2200 
SDUC61AF 9.6 ± 0.5 0.017 ± 0.004 9300 ± 2300 
SDUC61SF 5.9 ± 0.2 0.012 ± 0.003 8300 ± 1800 
SDUC104AF 0.9 ± 0.1 0.023 ± 0.001 640 ± 200 
SDUC104SF 2.7 ± 0.1 0.016 ± 0.004 2800 ± 670 
SDUC35A/C61AF 6.4 ± 0.2 0.010 ± 0.002 10600 ± 2300 
        
 
 
ISCU2 Conserved Cysteine Residues are Critical for Enzymatic Fe-S Cluster Assembly   
We then measured Fe-S cluster formation rates for ISCU2 variants using two 
different spectroscopic assays. First, the increase in absorbance at 456 nm was used as a 
measure of the Fe-S cluster biosynthetic activity. The ISCU2 C96S variant, which is the 
non-conserved cysteine, had a Fe-S cluster assembly activity similar to the native SDU 
and SDUF complexes (Figure 2.7A), indicating that this residue is neither essential for 
cluster ligation nor for the mechanism of cluster formation. In contrast, SDUF 
complexes containing the C35A, C61A, and C104A ISCU2 variants had a dramatic loss 
of activity relative to native SDUF (Figure 2.7A). Interestingly, there is a low level 
increase in absorbance for samples containing the C35A, C61A, and C104A variants or 
the native ISCU2 in the absence of FXN. Second, we monitored the 300-600 nm region 
using circular dichroism (CD) spectroscopy, which is sensitive to the PLP cofactor and 
to protein-bound Fe-S cluster species. A CD signal with maxima at 330 and 430 nm  
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developed for samples of the Fe-S assembly complex containing native ISCU2 or the 
C96S variant (Figure 2.7B) that appeared similar to [2Fe-2S] cluster bound to bacterial 
IscU
79
. The development of this Fe-S signal was absent for assembly complex samples 
that contained the C35A, C61A, and C104A variants. These samples did have a CD 
signal that maximized at 420 nm, but this signal is due to the PLP cofactor of NFS1 
rather than an Fe-S cluster. Together, these data indicate that C96 is not required for the 
Fe-S assembly reaction, which all three conserved cysteine residues (C35, C61, and 
C104) are essential for enzymatic Fe-S cluster formation, and suggest that C104 is 
linked to FXN activation and sulfur transfer chemistry. 
Discussion 
Despite many excellent studies of the ISC biosynthetic system, details of the 
sulfur transfer mechanism and intermediates in Fe-S cluster biosynthesis remain 
 
Figure 2.7. Conserved cysteine residues are critical for Fe-S cluster formation on ISCU2. (A) Fe-S 
cluster formation was monitored at 456 nm by UV-Vis spectroscopy as a function of time. (B) Fe-S 
cluster formation was monitored by CD spectroscopy and the 60 minute time point is displayed. 
Samples include SDU (yellow), SDUF (red), SDUC35AF (blue), SDUC61AF (black) SDUC96SF 
(purple), SDUC104AF (green).   
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unknown. Currently, two minimalist models have been proposed for Fe-S cluster 
biosynthesis that differ in the order of substrate addition: the sulfur-first and iron-first 
mechanisms.
38
 In the sulfur-first mechanism, the first step is transfer of the terminal 
sulfur of a persulfide species on the cysteine desulfurase (bacterial IscS or human NFS1) 
to a cysteine residue on the scaffold protein (bacterial IscU or human ISCU2).
92
 This is 
followed, in an undefined order, by a second sulfur transfer event, the incorporation of 
two ferrous irons, and the addition of two electrons to form a [2Fe-2S]
2+
 intermediate.  
This model is supported by the ability of E. coli and A. vinelandii IscS to transfer sulfur 
from L-cysteine to form persulfide or polysulfide bound IscU.
42, 43
 In the Fe-first 
mechanism, ferrous iron binds to the cysteines of the scaffold protein as an initiating step 
in forming the [2Fe-2S]
2+
 intermediate. This model is supported by the ability of the 
Thermotoga maritima IscU to bind ferrous iron
40
 and by the stabilization of the 
Haemophilus influenza IscU by binding of divalent metal ions such as zinc to the active 
site cysteines
93, 94
. However, neither the persulfide-bound nor iron-bound IscU has been 
demonstrated to be a viable intermediate in Fe-S cluster biosynthesis.   
Even less is known about the sulfur transfer mechanism in eukaryotes, and two 
additional components (FXN and ISD11) are implicated in modulating the cysteine 
desulfurase activity of NFS1.
22, 29, 30, 82-85
 Here our objective was to directly test if a 
persulfide generated on ISCU2 is viable in forming a Fe-S cluster. Our strategy was to 
track the 
35
S-radiolabel from a cysteine substrate to a persulfide species on the human 
Fe-S cluster assembly complex, and then show that this persulfide species is viable in 
forming an iron-sulfur cluster on an acceptor protein. The addition of a L-[
35
S]-cysteine 
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substrate to the SDUF complex resulted in co-migration of the radiolabel with both 
NFS1 and ISCU2 on an non-reducing SDS-PAGE gel (Figure 2.4) and addition of 
reductants such as DTT, GSH, BME, or TCEP decreased the label on NFS1 and ISCU2 
(data not shown), consistent with the formation of a covalent adduct. As the labeling 
experiments were performed under anaerobic conditions and the excess label was 
removed before analyzing with SDS-PAGE, the covalent adduct is likely a persulfide 
species rather than a cystine formed by oxidative disulfide bond formation between a 
radiolabeled cysteine and a cysteine residue on NFS1 or ISCU2. This SDUF complex 
with a persulfide-bound ISCU2 subunit was then reacted with iron and additional non-
radiolabeled cysteine, desalted, and then incubated with apo-FDX. Our results indicate 
the radiolabel was transferred to FDX and was associated with a DTT-resistant species 
that absorbs at 405 nm (Figure 2.4), which is consistent with a Fe-S cluster and not a 
persulfide species. Together these experiments show that a persulfide species can be 
formed on the ISCU2 subunit of the SDUF complex and this species has properties 
consistent with an intermediate, which supports a sulfur-first mechanism in eukaryotic 
Fe-S cluster biosynthesis. 
Three conserved cysteines in ISCU2, C35, C61, and C104, are required for 
efficient Fe-S cluster formation based on absorbance at 456 nm and a CD assay for 
protein-bound [2Fe-2S] clusters (Figure 2.7), whereas only C104 is required for FXN-
activation of the NFS1 cysteine desulfurase activity (Table 2.2). One possibility is that 
the loss of cysteine desulfurase activity for C104 variants is simply due to loss of protein 
conformation (switching between order and disorder states). We disfavor this possibility 
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as the exclusive cause of these effects because of the conservative nature of the 
substitutions and lack of correlation between cysteine desulfurase activation level and 
relative ISCU2 and FXN binding to the SD complex (Table 2.1), which is an indirect 
reporter of conformational state. A second possibility is that C104 functions as a sulfur 
acceptor in the interprotein sulfur transfer reaction, and the ability to transfer sulfur from 
NFS1 to C104 ISCU2 (followed by DTT cleavage) is responsible for the enhanced 
cysteine desulfurase activity. A third possibility is that one of the other cysteines is the 
sulfur acceptor and the enhanced cysteine desulfurase activity is due to interprotein 
sulfur transfer from NFS1 to C35 or C61, followed by intraprotein sulfur transfer to 
C104 and reductive cleavage to generate sulfide. To test this third possibility, we 
constructed and characterized the C35A/C61A variant and determined that it exhibited a 
kcat for the cysteine desulfurase activity that was more similar to native ISCU2 than to 
the C104 variants (Table 2.2). Thus, we favor a model in which C104 acts as a primary 
rather than secondary sulfur acceptor and this sulfur species partitions in our assays 
between being intercepted and reductively cleaved to produce sulfide, and functioning as 
an intermediate in Fe-S cluster formation on the assembly complex. This is a different 
conclusion than that obtained for the E. coli ISC system in which all three conserved 
cysteines were shown to be dispensable for Fe-S cluster formation using sulfide 
(chemical reconstitution conditions) as the sulfur source.
79
  This apparent contradiction 
might be explained by differences in reaction conditions that favor the assembly 
complex and the previous studies that favor the E. coli IscU dimer. Dimeric IscU can 
likely overcome the loss of one of the three conserved cysteines and still ligate a Fe-S 
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cluster with the remaining four cysteines. In addition, Bonomi et al. showed that residue 
C106 in E. coli IscU (equivalent to C104 of human ISCU2) is required for Fe-S cluster 
formation in assays using IscS and proposes that C106 functions in sulfur transfer 
chemistry.
79
 Despite different experiments and results, we have a similar conclusion and 
provide data consistent with C104 being the primary sulfur acceptor from NFS1 and the 
resulting persulfide species on ISCU2 functioning as an intermediate in human Fe-S 
cluster biosynthesis.   
FXN accelerates both the cysteine desulfurase (sulfide production) and Fe-S 
assembly (increase in absorbance at 456 nm) activities of the human SDU complex.
22
  
FXN could stimulate the rates of these reactions by inducing a conformational change 
that (i) increases active site accessibility; (ii) enhances a step associated with PLP 
chemistry on NFS1; and/or (iii) facilitates interprotein sulfur transfer from NFS1 to 
ISCU2. The first mechanism suggests a FXN-dependent increase in active site 
accessibility that allows DTT to intercept a catalytic intermediate and generate sulfide, 
which could drive non-enzymatic assembly of Fe-S clusters.
3
 This explanation would 
predict that the rates of the cysteine desulfurase and Fe-S assembly reactions should be 
correlated, which is not true for the SDUC35AF and SDUC61AF complexes that exhibit 
native like cysteine desulfurase activities (Table 2.2), but compromised Fe-S cluster 
assembly activities (Figure 2.7). The second mechanism, involving enhancement of 
persulfide formation on NFS1, suggests that FXN but not FRDA FXN variants should 
increase the level of 
35
S radiolabel accumulation on NFS1, which was observed (Figure 
2.2 and 2.3). Previous results
22
 and data provided here (Table 2.2) indicate that FXN 
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affects the KM for L-cysteine in the cysteine desulfurase reaction, and is consistent with 
recent results in Saccharomyces cerevisiae.
95
 The third mechanism, involving a FXN-
dependent acceleration of interprotein sulfur transfer, is more difficult to separate from 
acceleration of a rate-limiting formation of a persulfide on NFS1, despite the increase in 
accumulation of the 
35
S radiolabel on ISCU2 (Figure 2.2). However, the fact that the 
cysteine desulfurase kcat values for the C104 ISCU2 variants were reduced to levels 
similar to the Fe-S assembly complex without FXN suggest that this residue is involved 
in the sulfur transfer chemistry and FXN-activation (Table 2.2). Taken together, these 
data are consistent with a role for FXN in accelerating both the persulfide formation on 
NFS1 as well as interprotein sulfur transfer to ISCU2.  
We propose that a key aspect of the cysteine desulfurase and Fe-S assembly by 
the human Fe-S assembly complex revolves around the accessibility of ISCU2 C104 
(Figure 2.8), which is reminiscent of the ordered and disorder equilibrium for E. coli 
IscU proposed by the Markley lab.
96, 97
 The crystal structure of the trimeric Aquifex 
aeolicus IscU reveals a distinct helix-to-coil transition for the vicinity of C104 based on 
the presence (subunit B) or absence (subunits A and C) of a Fe–S cluster.54 Similarly, we 
propose a pre-equilibrium mixture between non-functional (helix) and functional (coil) 
states in the C104-containing helix of ISCU2 that shifts upon FXN binding from the 
non-functional to functional form to facilitate sulfur transfer from NFS1 C381 to ISCU2 
C104. The proposed helix-to-coil transition could also expose the LPPVK motif (residue 
97-101 in ISCU2) to adopt a flexible conformation promoting the binding of chaperones 
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involved in cluster transfer.
98, 99
 At this stage it is unclear if and what triggers holo-
ISCU2 dissociation from the Fe-S assembly complex and what assembly state interacts 
with molecular chaperone and target proteins. Our in vitro results and our model suggest 
FXN functions as an allosteric regulator that controls Fe-S cluster assembly. Such a 
function would be consistent with the generally accepted role for FXN in Fe-S cluster 
assembly and explain the loss of Fe-S enzyme activity phenotype upon FXN depletion. 
Future experiments will focus on testing and expanding upon this model with the 
ultimate goal of developing new strategies to treat FRDA. 
 
 
 
Figure 2.8. Cartoon model of FXN activation of the Fe-S assembly complex. (A) SDU complexes 
exist as an equilibrium mixture between a stable inactive (helix) and less stable active (coil) 
conformation. (B) FXN binds to the coil conformation for the C-terminal helix and shifts the 
equilibrium from the inactive to active form. (C) NFS1 reacts with L-cysteine to form a persulfide 
species on residue C381. (D) Sulfur is transferred from NFS1 to ISCU2 residue C104. (E) Addition 
of the remaining substrates results in [2Fe-2S] cluster formation on ISCU2. (F) The Fe-S cluster is 
transferred to an apo target and the active SDUF assembly complex is reformed. This last step may 
involve subunit dissociation and/or chaperone proteins.  
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Conclusion 
In summary, we provide data that support a role for human FXN in accelerating 
the PLP-based chemistry of the cysteine desulfurase NFS1 and also in the interprotein 
sulfur transfer between NFS1 and scaffold protein ISCU2. Our results are consistent 
with ISCU2 residue C104 being the sulfur acceptor and the resulting intermediate being 
an early step in Fe-S cluster assembly. We propose a testable activation model in which 
FXN facilitates a helix-to-coil activation model for sulfur transfer. These in vitro results 
suggest FXN may have a physiological function as a regulator and that FXN levels 
control Fe-S cluster assembly. Such a function would be consistent with the generally 
accepted role for FXN in Fe-S cluster assembly and explain the loss of Fe-S enzyme 
activity phenotype upon FXN depletion. Future experiments will focus on testing and 
expanding upon this model with the ultimate goal of developing new strategies to treat 
FRDA.  
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CHAPTER III 
THE HUMAN FE-S ASSEMBLY COMPLEX GENERATES TRANSIENT [2FE-2S] 
CLUSTER INTERMEDIATES THAT READILY TRANSFER TO THIOL-
CONTAINING TARGET MOLECULES 
 
Introduction 
Iron-sulfur (Fe-S) clusters are protein cofactors that are required for many critical 
cellular functions including oxidative respiration, DNA repair, and the biosynthesis of 
other cofactors.
1
 The most common role for Fe-S clusters is in electron transfer 
reactions, but additional functions such as substrate turnover, environmental sensing, and 
protein stabilization are also known. Fe-S clusters with different iron and sulfide 
stoichiometries, including common rhombic [2Fe-2S] and cubic [4Fe-4S] and more 
specialized [3Fe-4S], [4Fe-3S], and [8Fe-7S] clusters, are fine-tuned by the protein 
environment to have the necessary chemical properties for their function. Spectroscopic 
features can often distinguish these different classes of Fe-S clusters. For example, [2Fe-
2S]
2+
 clusters exhibit characteristic electronic absorbance (315, 400, and 456 nm) and 
circular dichroism (CD) (330 and 430 nm) peaks and diagnostic Mössbauer parameters 
(δ = 0.25-0.30 mm/s and ΔEQ = 0.7-0.8 mm/s), whereas [4Fe-4S]
2+
 clusters have broad 
electronic absorbance spectra (peak at ~400 nm), are often CD silent, and exhibit 
Mössbauer signals with very different parameters (δ = 0.40-0.45 mm/s and ΔEQ = 1.1-
1.5 mm/s).
3, 44, 100-103
 Remarkably, the Holm group and others have demonstrated that 
these biological Fe-S clusters can be self-assembled in solution from iron, sulfide and 
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appropriate sulfur-containing ligands,
3, 4
 and it is common to reconstitute recombinant 
Fe-S cluster proteins using similar conditions. Interestingly, the in vivo synthesis of Fe-S 
clusters does not use this self-assembly chemistry, but synthesizes Fe-S clusters using 
highly conserved proteins that are part of Fe-S cluster assembly pathways.
5-7
 
The prokaryotic ISC, NIF, and SUF systems enzymatically build Fe-S clusters 
from substrates L-cysteine, iron, and electrons. As biological Fe-S clusters have been 
shown to self-assemble in solution, these enzymatic systems may not be necessary to 
form the specific Fe-S bonds, but to control the iron and sulfur reactivity/toxicity and 
regulate the amounts of different types of clusters that are synthesized. Here we focus on 
the ISC pathway. The prokaryotic ISC pathway is probably the best studied and is 
analogous to the eukaryotic Fe-S biosynthetic pathway that is located in the 
mitochondrial matrix and includes at least a dozen proteins.
2, 5, 16
 A cysteine desulfurase 
(human NFS1 or bacterial IscS) catalyzes the PLP-dependent conversion of L-cysteine to 
L-alanine, generates a persulfide species on a mobile loop cysteine, and delivers the 
sulfane sulfur to the Fe-S catalytic or scaffold subunit (human ISCU2 or bacterial 
IscU).
25, 26
 The cysteine desulfurase activity is often measured by intercepting this 
persulfide species using reductive thiol-cleaving reagents such as DTT and quantitating 
the generate sulfide.
27
 Isd11 is a eukaryotic-specific protein that appears to stabilize the 
cysteine desulfurase and may participate in positioning the mobile loop cysteine for 
attack of the substrate.
28-32
 Human frataxin (FXN) stimulates the cysteine desulfurase 
reaction and may functions as an allosteric activator to regulate the Fe-S assembly 
complex.
22
 FXN also appears to simulate the rate of in vitro Fe-S cluster assembly, 
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whereas the bacterial homolog CyaY appears to inhibit Fe-S biosynthesis.
22-24
 FXN has 
also been proposed,
19, 20
 along with IscA,
21
 to function as an iron donor for Fe-S cluster 
biosynthesis, whereas the ferredoxin/ferredoxin reductase system is thought to provide 
electrons.
33, 34
 In vitro Fe-S assembly reactions often use a surrogate electron donor such 
as DTT rather than the ferredoxin/ferredoxin reductase system. Finally, chaperone and 
Fe-S carrier proteins appear to facilitate the transfer of intact Fe-S clusters from the Fe-S 
assembly complex to target proteins.
35, 36
 
The prokaryotic scaffold protein IscU combines sulfur generated from cysteine 
by the cysteine desulfurase, iron, and electrons to synthesize [2Fe-2S] and [4Fe-4S] 
clusters. Currently, no intermediates in generating [2Fe-2S] clusters are established in 
the biosynthetic system or self-assembly process, but some details of the conversion of 
[2Fe-2S] clusters to [4Fe-4S] clusters are known. Inorganic biomimetic chemistry 
revealed that [4Fe-4S] clusters can be formed by reductively coupling two [2Fe-2S] 
clusters,
3
 whereas studies of the oxygen sensor protein FNR reveal the conversion of 
persulfide ligated [2Fe-2S] cluster to cysteine ligated [4Fe-4S] cluster upon the addition 
of iron.
51
 In key early studies on biosynthetic systems, Agar et al. demonstrated that 
[2Fe-2S] clusters can be assembled on IscU in an IscS mediated process,
52
 and Foster et 
al. showed that the human ISCU2 D37A variant contains a stable [2Fe-2S] cluster.
53
 
IscU binds clusters with three conserved cysteines,
50
 with experimental support for a 
semi-conserved histidine,
46, 54
 aspartic acid,
55
 and a cysteine from another molecule
56, 57
 
as the fourth ligand. In a remarkable study, the Huynh, Dean, and Johnson groups 
demonstrated reductive coupling chemistry on an IscU dimeric species with the 
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sequential formation of a single [2Fe-2S] cluster, a second [2Fe-2S] cluster, and then 
conversion of these [2Fe-2S] clusters to form one [4Fe-4S] cluster per IscU dimer.
48
 
This reductive coupling chemistry appears to occur at an IscU dimeric interface with 
each monomer contributing one [2Fe-2S] cluster. 
An Fe-S assembly complex appears to be responsible for the synthesis of [2Fe-
2S] and possibly [4Fe-4S] clusters for the ISC pathway. A protein complex between 
bacterial IscS and IscU has been demonstrated in solution,
42, 58
 and crystal structures 
with
56
 and without
59
 a [2Fe-2S] cluster provide details of the protein-protein interactions 
and cluster environment. An apparent key to obtaining a crystal structure of the bound 
[2Fe-2S] cluster was the incorporation of the D35A variant,
56
 which was previously 
shown to stabilize the cluster bound state and/or inhibit cluster transfer.
53, 60, 61
 
Interestingly, Mössbauer spectroscopic studies suggest the addition of L-cysteine, ferrous 
iron, and DTT to the bacterial and mammalian Fe-S assembly complexes results in the 
formation of [2Fe-2S] and [4Fe-4S] cluster species.
62, 63
 These results suggest at least 
two models. In the first model, IscU subunits dissociate after building [2Fe-2S] clusters, 
and this dissociated [2Fe-2S]-bound IscU undergoes reductive coupling chemistry to 
generate [4Fe-4S] clusters. In the second model, [2Fe-2S] clusters synthesized on the Fe-
S assembly complex transform to [4Fe-4S] clusters through chemistry that may resemble 
the [2Fe-2S]  [4Fe-4S] conversion for FNR.51 The first model is supported by the 
ability of the scaffold protein to undergo reductive coupling chemistry,
48, 64
 whereas the 
second model is suggested by recent studies of a eukaryotic Fe-S assembly complex.
62
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Here our objectives were to utilize spectroscopic methods to determine 
intermediates associated with the synthesis of Fe-S clusters by the human assembly 
complex. Previously, the kinetics of enzymatic Fe-S cluster formation was measured 
using the increase in absorbance due to sulfur-to-iron charge transfer bands.
22, 23, 46, 96
 
The human Fe-S assembly complex consisting of NFS1, ISD11, and ISCU2 subunits 
(named SDU) exhibited low cysteine desulfurase activity and a slow increase in 
absorbance at 456 nm that was attributed to the Fe-S synthesis reaction.
22
 Addition of 
FXN generated the SDUF complex, which exhibited greatly enhanced rates for the 
cysteine desulfurase and Fe-S cluster assembly reactions.
22
 Here we apply UV-visible, 
circular dichroism, and Mössbauer spectroscopy to reveal details of the Fe-S cluster 
assembly reaction on the SDUF complex and competing DTT-mediated transfer and 
mineralization chemistry that have implications for the mechanism and study of Fe-S 
cluster biosynthesis. 
Experimental Procedures 
Protein Expression and Purification  
NFS1-ISD11 (named SD), ISCU2, and FXN were purified as previously 
described.
22
 Briefly, plasmids that contain the genes for human SD, ISCU2, and FXN 
were individually transformed into BL21(DE3) cells and grown at 37 °C until reaching 
an OD600 of 0.6. Protein expression was induced with either 0.5 mM (ISCU2 and FXN) 
or 0.1 mM (SD) IPTG, the temperature was reduced to 16 °C, and the cells were 
harvested 16 hours later. The SDUF complex exhibited a cysteine desulfurase activity of 
11 mol sulfide/(mol NFS1)(min), which is similar to previously published values.
22, 24
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The plasmid PET9a encoding human ferredoxin (FDX; gift of John Markley)
90
 was 
transformed into E. coli BL21 (DE3) cells and grown at 37 ºC until an OD600 of 0.6. 
Expression was induced with 0.4 mM IPTG, 1 mM cysteine, and 0.1 mg/mL ferric 
ammonium citrate, and the cells were harvested 16 hours later. The cells were lysed by 
sonication, the soluble proteins were loaded onto an anion exchange column (26/20 
POROS 50HQ, Applied Biosystems), and eluted with a linear gradient from 0 to 1000 
mM NaCl in 50 mM Tris pH 7.5. Fractions containing FDX were further purified
91, 104
 
on a Sephacryl S100 (26/60, GE Healthcare) size exclusion column equilibrated in 50 
mM Tris, pH 7.4, 50 mM NaCl. Apo FDX was prepared by precipitating purified FDX 
with 10% trichloroacetic acid, incubating with 10 mM DTT on ice for 10 minutes, 
pelleting the sample, rinsing the pellet with water two times, and resuspending the pellet 
anaerobically in 50 mM Tris pH 8.0, 250 mM NaCl.
104
 Unless otherwise stated, 
anaerobic experiments were performed in a Mbraun glovebox at ~12 °C with an argon 
atmosphere and O2 < 1 ppm as monitored by a Teledyne Model 310 analyzer. 
Fe-S Cluster Formation Assays  
The Fe-S cluster assembly assay mixtures under five different experimental 
conditions (Standard, DTT-free, Stoichiometric, Catalytic and Acceptor) were prepared 
anaerobically and transferred to an anaerobic cuvette for UV-visible (Agilent UV-
Visible 8453) and circular dichroism (CD; Chirascan
TM
) data collection at 20 ºC. 
Standard assay conditions include 10 μM SD, 30 μM ISCU2, 30 μM FXN with 4 mM 
DTT, 100 μM cysteine and either 250 μM or 400 μM Fe(NH4)2(SO4)2. The DTT-free 
conditions were the same as the standard conditions except the L-cysteine concentration 
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was increased to 1 mM, samples lacked DTT, and the Fe(NH4)2(SO4)2 concentration was 
changed from 400 to 250 μM. Stoichiometric conditions included 10 μM SD, 10 μM 
ISCU2, 30 μM FXN with 1 mM cysteine and 250 μM Fe(NH4)2(SO4)2. Catalytic 
conditions included 0.5 μM SD, 30 μM ISCU2, and 30 μM FXN with 250 μM 
Fe(NH4)2(SO4)2 and 1 mM cysteine. The Acceptor conditions included 4 μM SD, 30 μM 
ISCU2, 30 μM FXN, 90 μM apo FDX, 250 μM Fe(NH4)2(SO4)2, 1 mM cysteine with or 
without 4 mM DTT. Extinction coefficients of 16 mM
−1
cm
−1
 at 400 nm
105, 106
 and 5.8 
mM
−1
cm
−1
 at 456 nm
48
 were used to quantitate [4Fe-4S] and [2Fe-2S] clusters, 
respectively. 
Protein Assembly State Analysis  
Sample mixtures of 50 μM SD plus 150 μM ISCU2 with (SDUF) or without 
(SDU) 150 μM FXN were incubated anaerobically for 20 minutes at 10 °C with 1.5 mM 
DTT and 500 μM of Fe(NH4)2(SO4)2, L-cysteine, or both Fe(NH4)2(SO4)2 and L-
cysteine. Samples were applied to an anaerobic S-200 column (GE 26/60 Sephacryl S-
200 High Resolution) equilibrated with 50 mM HEPES pH 7.8, 250 mM NaCl (Buffer 
A).  In second set of experiments, NFS1 was alkylated by incubating 50 μM SD with 1 
mM iodoacetamide for 1 hr at 12 °C, quenched with 10 mM cysteine, and modifications 
to C381 was confirmed by mass spectrometry. Alkylated or non-alkylated SD was 
reacted for 15 minutes at 12 °C with 50 μM ISCU2, 50 μM FXN, 200 μM 
Fe(NH4)2(SO4)2, 1.5 mM DTT, and 200 μM Na2S, and applied to the S-200 column. In a 
third set of experiments, 100 μM SDUF was prepared by addition of 100 µM SD with 
300 µM ISCU2 and 300 µM FXN and was reacted for 45 min at 12 °C with 1 mM 
  49 
Fe(NH4)2(SO4)2, 1 mM L-cysteine, and 3 mM DTT in the presence and absence of 500 
μM apo FDX, and applied to the S-200 column. The reaction without apo FDX was 
repeated and the High Molecular Weight Species (HMWS) was isolated from the S-200 
column. The HMWS sample was split and (i) incubated for 10 min with 4 mM DTT; and 
(ii) incubated for 40 min with 500 μM apo FDX and 4 mM DTT. Both samples were 
applied to a S-200 column. The HMWS eluted at the void volume for the S-200 column 
(8 mL), the SDU and SDUF complexes eluted at 12 mL, and uncomplexed ISCU2, 
FXN, and FDX eluted at 16 mL. Calibration with molecular weight standards confirmed 
that the protein samples eluted at volumes consistent with their known molecular 
masses. Sulfide production was measured using methylene blue assay,
22, 107, 108
 whereas 
iron quantitation was achieved with a Ferrozine assay.
109-112
  
Mössbauer Analysis of Fe-S Species  
Mössbauer was used to analyze three HMWS samples, an Fe-S assembly 
reaction coupled to CD spectroscopy, and an Fe-S assembly reaction with and without 
DTT. The first HMWS sample was prepared by reacting 600 μM SD with 6 mM L-
cysteine, 6 mM 
57
Ferric citrate, and 1.8 mM DTT for 45 min at 12 °C, and isolating the 
HMWS using a S-200 column equilibrated in Buffer A.  The second HMWS sample was 
prepared identically but Mössbauer spectras were collected at 5 and 100 K.  In the third 
HMWS sample 2.4 mM cysteine was slowly added (10 μM per minute) to a solution of 
600 μM SDUF, 2.4 mM 57Ferric citrate, and 10 mM glutathione, the sample was 
incubated at 12 °C for 1 hour, and applied to the S200 column. In the Fe-S assembly 
reaction coupled to CD spectroscopy, 8 μM SD, 200 μM ISCU2, and 8 μM FXN was 
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combined with 500 μM 57Fe2+ and 1 mM L-cysteine in a total volume of 8 mL, and a 
portion was removed to monitor reaction progress at 20 °C with CD spectroscopy. 
57
Ferrous was made by the reduction of a 80 mM 
57
Ferric citrate stock solution by 
dithionite that was carefully monitored by Mössbauer spectroscopy to generate 100% 
reduced iron with no excess dithionite. After 45 minutes, the rest of the 8 mL sample 
was concentrated to 800 μL, diluted to 3 mL, and re-concentrated to 800 μL three times 
before analysis by LC-ICP-MS (see below) and Mössbauer spectroscopy. In the final 
sample, 10 μM SD, 1300 μM ISCU2, 1.5 mM 57Fe2+ and 10 mM L-cysteine were 
combined in a total volume of 1600 μL. The ferrous was slowly added to Fe-S assembly 
reaction (375 μM per hour). The sample was incubated for 1 hour at 12 °C and then split 
split in half. Half of the sample was incubated with 10 mM DTT for 1 hour and then 
both samples were separately analyzed by LC-ICP-MS (see below) and Mössbauer 
spectroscopy. Low-field Mössbauer spectra were collected using a model MS4 WRC 
spectrometer (SEE Co, Edina MN) at 5K and analyzed using WMOSS software (SEE 
Co, Edina MN).  The parameters are reported relative to α-Fe foil at 298 K. 
LC-ICP-MS Analysis  
A Superdex 200 (10/300, GE Healthcare) was equilibrated with 50 mM Tris-
HCl, 150 mM NaCl, pH 7.4 buffer. The buffer was prepared in double-distilled 
deionized trace-metal-free water. The elution flow rate was 0.5 mL/min
−1
, controlled by 
a Bio-Inert HPLC (Agilent Technologies). A variable wavelength diode array detector 
(Agilent Technologies) was positioned post column and set to 280 nm. The entire system 
was housed in a ~7 °C Mbraun glovebox with O2 < 3 ppm. The post detector flow was 
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split using a micro splitter valve (Upchurch Scientific, USA) with 30% directed to the 
ICP-MS and the remainder to a 1260 Infinity Analytical-Scale Fraction Collector 
(Agilent Technologies). The 7700x ICP-MS (Agilent Technologies) was used in 
collision cell mode (He: 4.3 mL min
−1
) with platinum cones and skimmer to minimize 
polyatomic inferences. The instrument was optimized daily using manufacturer's tuning 
solution. The sample was introduced through a standard Micromist nebulizer (Glass 
Expansion, Australia). 
56
Fe and 
57
Fe were monitored with a dwell time of 100 ms.  
Results  
Standard Assay Conditions Generate Fe-S Species not Associated with SDUF Complex  
Fe-S assembly complexes were prepared anaerobically in a glovebox, placed in a 
sealed cuvette, and assayed for Fe-S cluster assembly activity under five different sets of 
conditions: Standard, DTT-free, Stoichiometric, Catalytic and Acceptor (see Methods). 
A Standard Fe-S assembly reaction, which includes substrates L-cysteine and 
Fe(NH4)2(SO4)2, and uses DTT as the electron source, was initiated by the addition of L-
cysteine with a gas-tight syringe, and the absorbance spectrum was monitored as a 
function of time. The absorbance spectrum at the end of the reaction exhibited a broad 
absorbance peak that maximized at 400 nm that is reminiscent of [4Fe-4S] clusters 
(Figure 3.1A). Examining the change in absorbance at 400 nm revealed an immediate 
increase in absorbance that appears to saturate at > 20 minutes (Figure 3.1B). CD spectra 
for the SDUF sample under Standard conditions revealed a peak at 420 nm and a slight 
decrease in 300-350 nm ellipticity over time (Figure 3.2A). Control reactions that lacked 
  52 
  
 
Figure 3.1. Fe-S cluster formation for SDUF complex in the presence of DTT. 
(A) Final Fe-S cluster absorbance spectrum and (B) kinetics monitored at 400 
nm for reaction of SDUF (1:3:3 SD:ISCU2:FXN) with L-cysteine, Fe
2+
, and 
DTT under Standard conditions (see Methods).  
 
Figure 3.2. SDUF Fe-S assembly reactions in the presence of DTT exhibit 
PLP but not Fe-S CD features. CD spectra overlaid for the Fe-S assembly 
reaction under Standard conditions in the presence (A) and absence (B) of iron.  
Complete assembly reactions in (A) were collected at 0 (black), 20 (red), 40 
(green), and 90 (blue) minutes. Control reactions in (B) included 10 mM 
EDTA and revealed changes due to the PLP cofactor at 0 (black), 10 (red), 20 
(green), and 40 (blue) minutes.  
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 iron (Figure 3.2B) revealed these changes were due to the PLP cofactor.  Samples of the 
SD complex and E. coli IscS also exhibit the 420 nm peak. Previously, [2Fe-2S], but not 
[4Fe-4S], clusters were shown to exhibit characteristic strong CD features for bacterial 
IscU.
36, 40, 44
 The electronic absorbance and CD spectroscopic data are therefore 
consistent with the SDUF complex facilitating rapid formation of a [4Fe-4S] cluster (or 
Fe-S species with similar spectroscopic properties) and provide no evidence for an [2Fe-
2S] intermediate under Standard conditions. A [4Fe-4S] cluster assignment would result 
in similar concentrations (Table 3.1) of [4Fe-4S] clusters (27 M) and ISCU2 (30 M) 
and suggest saturation of the ISCU2 binding sites. However, as the concentration of SD 
was only 10 M, this indicates at least some Fe-S species not associated with the SDUF 
complex. Based on these data our initial hypothesis was that SDUF reactions under 
Standard conditions generated [4Fe-4S] clusters associated with uncomplexed 
monomeric ISCU2.  
Discovery of Fe-S Associated High Molecular Weight Species (HMWS)  
To test our initial hypothesis, Fe-S assembly assays under Standard conditions 
were coupled to anaerobic analytical size exclusion analysis to determine protein species 
(uncomplexed ISCU2 or SDUF) associated with Fe-S clusters. Unexpectantly, Fe-S 
assembly reactions using either the SDU or SDUF complex resulted in the formation of 
a high molecular weight species (HMWS) that elutes at the void volume (7-11 mL) of 
the analytical S-200 column (Figure 3.3). The HMWS only formed for SDU and SDUF 
samples if iron and cysteine were included in the reaction mixture (Figure 3.3), and the 
rate of HMWS formation was increased by DTT (data not shown). Iron and sulfide co- 
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Table 3.1. Quantification of the Fe-S Cluster Generated from the SDUF Complex  
Reductant 
SD 
µM 
ISCU2 
µM 
Fe
2+
 
µM 
Cys 
mM 
Cluster 
µM 
DTT 10 30 400 0.1 27 
Cys 10 30 250 1.0 125 
 
 
 
 
eluted from the S-200 column primarily with the HMWS rather than SDU, SDUF, or 
uncomplexed ISCU2, and the HMWS was associated with brown color, which is 
consistent with an Fe-S species. Thus, the electronic absorbance spectroscopic features 
(Figure 3.1A) generated by the SDUF complex under Standard Fe-S assembly reaction 
 
 
Figure 3.3. Discovery of HMWS formation during Fe-S assembly reactions. Fractions from 
anaerobic S-200 column for SDU (A) and SDUF (B) samples and addition of DTT (black), Fe
2+
 
and DTT (green), cysteine and DTT (blue), or cysteine, Fe
2+
 and DTT (gold). HMWS elutes at 
void volume (~8mL), native SDUF, SDU, and SD complexes elute at ~12 mL, and uncomplexed 
ISCU2 and FXN elute at 16 mL. The spectrums from S-200 column were monitored at 280 nm. 
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conditions are likely associated with the HMWS. Next, we tested if the HMWS could be 
a large assembly complex of possible physiological significance by evaluating the ability 
of this species to insert an Fe-S cluster into apo human Ferredoxin (FDX). Addition of 
excess apo FDX at the beginning of the experiment resulted in a decrease in the HMWS 
absorbance peak and an increase in the native assembly complex and FDX absorbance 
peaks compared to the control reaction (Figure 3.4A). The absorbance at 405 nm was 
monitored for these fractions and indicated protein species associated with either Fe-S 
clusters or the PLP cofactor. Thus, it appears that the addition of apo FDX at the start of 
the experiment resulted in: (i) enzymatic assembly or chemical reconstitution of Fe-S 
clusters on FDX that bypassed HMWS formation; and/or (ii) formation of the HMWS 
that converted back to the Fe-S assembly complex by transferring Fe-S clusters to FDX. 
To test if the HMWS can transfer a cluster to apo FDX, we isolated the HMWS and split 
it into two fractions, incubated one fraction with DTT and the other with both DTT and 
apo FDX, and separately analyzed the fractions with anaerobic S-200 chromatography. 
The apo FDX fraction exhibited a decrease in absorbance at 405 nm for the HMWS peak 
and an increase in absorbance for the native assembly complex and FDX (Figure 3.4B). 
The ability of the HMWS to build and transfer Fe-S cluster species to apo acceptor 
proteins is consistent with the HMWS being part of the biosynthetic assembly pathway 
or participating in a chemical reconstitution reaction. 
The HMWS appears to be an Fe-S material that associates with cysteine-
containing proteins. Interestingly, the HMWS that formed from SDU or SDUF under 
Standard Fe-S assembly reaction conditions exhibited little ISCU2 and no FXN on SDS- 
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Figure 3.4. HMWS diminished by addition of apo FDX. (A) S-200 chromatographic 
analysis of SDUF Fe-S assembly reaction under Standard conditions in the absence 
(black) or presence (red) of apo FDX. (B) S-200 analysis of isolated HMWS incubated 
with DTT (black) or apo FDX (red). The absorbance was monitored at 405 nm which is 
sensitive to Fe-S clusters and the PLP cofactor. 
 
 
Figure 3.5. Discovery of HMWS formation from Figure 3 during Fe-S assembly 
reactions. Fractions from anaerobic S-200 column for SDU (A) and SDUF (B). HMWS 
elutes at void volume (~8mL), native SDUF, SDU, and SD complexes elute at ~12 mL, 
and uncomplexed ISCU2 and FXN elute at 16 mL. The SDS-PAGE analysis of HMWS 
(lane 1, fraction 9), native complexes (lane 2, fraction 12) and uncomplexed ISCU2 and 
FXN (lane 3, fraction 16) from the S-200 column.  
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PAGE (Figure 3.5). As a control, the same Fe-S assembly reaction was repeated with SD 
and a similar HMWS was generated (Figure 3.6A). Further, generation of the HMWS is 
not specific to the human cysteine desulfurase as assays with E. coli IscS generated 
similar results (Figure 3.7). This suggests the HMWS is associated with the cysteine 
desulfurase. Since the ISUC2 scaffold protein is not a required component for the 
formation of the HMWS, the HMWS is likely the product of an iron and sulfide 
dependent chemical reconstitution process rather than some type of physiological 
supermacromolecular transfer complex. The cysteine desulfurase could be required 
simply to produce sulfide in these reactions. This hypothesis was tested in two ways. 
First, we substituted sulfide for L-cysteine and demonstrated that the HMWS is still 
formed in the presence, but not absence, of ferrous iron (Figure 3.6B).  Second, a sample 
in which the cysteines on NFS1 were alkylated was incubated with sulfide and ferrous 
iron. In this case, the HMWS failed to form (Figure 3.6B), indicating the formation of 
the HMWS requires iron, sulfide, and proteins with unmodified cysteines. Moreover, 
iron and sulfide quantitation for the HMWS from the SDUF Fe-S assembly reaction 
under Standard conditions revealed more iron and sulfide (9 Fe
2+
 and 10 S
2-
 per NFS1) 
than expected for a standard biological Fe-S cluster. This suggested some type of NFS1-
solubilized Fe-S mineral. To further test this hypothesis, the Standard Fe-S assembly 
reaction was allowed to reach saturation before being spiked with additional cysteine, 
which initiated further Fe-S synthesis (Figure 3.8). The saturation behavior in this assay 
was evidently not due to forming a specific cluster-bound intermediate on ISCU2, but  
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Figure 3.6. HMWS is formed under conditions inconsistent with enzymatic Fe-S cluster biosynthesis. 
(A) The SD complex was reacted with DTT, Fe
2+
, and L-cysteine. (B) The SDUF complex was 
incubated with DTT and reacted with S
2-
 (black), Fe
2+
 and S
2-
 (red), and, after alkylating NFS1 (see 
Methods), with Fe
2+
 and S
2-
. All samples applied to an anaerobic S-200 column and absorbance at 
280 nm was measured. The HMWS, cysteine desulfurase, and uncomplexed ISCU2 and FXN are in 
fractions 7-11, 11-13, and 16-17, respectively. 
 
 
Figure 3.7. E. coli IscS forms the HMWS during Fe-S assembly reactions. IscS was reacted 
with DTT, Fe
2+
, and L-cysteine and applied to an anaerobic S-200 column. The HMWS and 
cysteine desulfurase elute in fractions 9-12, and 13-14, respectively. 
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instead due to running out of substrate for formation of Fe-S species. Together, these 
data suggest a mineralization process that associates with cysteine-containing proteins.  
 Mössbauer spectroscopy supports the assignment of the HMWS as an Fe-S 
mineral. Interestingly, the HMWS exhibited electronic absorbance and CD spectroscopic 
properties reminiscent of [4Fe-4S] clusters, the ability to transfer Fe-S clusters to the 
[2Fe-2S] cluster binding protein FDX, and properties consistent with a solubilized Fe-S 
mineral. Mössbauer spectroscopy was used to further clarify the type of Fe-S cluster 
bound to the HMWS. Fe-S assembly reactions were performed with SD and SDUF 
under Standard conditions, the HMWS was isolated with a S-200 column, and the 
samples were frozen anaerobically for Mössbauer analysis. The HMWS from both SD 
and SDUF samples exhibited a high spin ferrous signal and a quadruple doublet with 
approximate parameters of δ = 0.35 mm/s and ΔEQ = 0.67 mm/s (Figure 3.9). The 
Mössbauer parameters for the quadruple doublet did not match the parameters for a 
[2Fe-2S]
2+
 or a [4Fe-4S]
2+
 cluster but were more consistent with those of a [2Fe-2S]
2+
 
cluster. The Mössbauer spectra for a separate HMWS sample exhibited 
superparamagnetic behavior in which an unresolved peak collapsed to a quadruple 
doublet at higher temperatures (Figure 3.10). In addition, incubation of the HMWS with 
excess dithionite did not result in an EPR active S = ½ state (data not shown), which 
argues against a standard [2Fe-2S]
2+
 or [4Fe-4S]
2+
 cluster. These spectroscopic 
properties are consistent with the HMWS being a solubilized Fe-S mineral, and are 
similar to properties of material isolated from chemical reconstitution reactions.
113
 
Together these results suggest that Fe-S biosynthetic and reconstitution assays that  
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Figure 3.8. SDUF Fe-S assembly reactions are limited by L-cysteine in the presence of 
DTT.  The SDUF Fe-S assembly reactions appear to saturate under Standard conditions.  
Addition of L-cysteine (arrow) results in additional Fe-S assembly.  
 
 
Figure 3.9. Mössbauer spectra determined for the HMWS. SDUF (red) and SD (black) Fe-S 
assembly reactions were performed under Standard conditions, the samples were applied to an 
anaerobic S-200 column, and the samples were frozen for Mössbauer analysis. The intensity is 
matched to show the overlap of the spectra.  The HMWS was five times more concentrated for 
the SD sample than the SDUF sample. 
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include or produce sulfide will likely generate Fe-S minerals and that this material will 
interact with cysteine-containing proteins to form HMWS. 
Generation of [2Fe-2S] Clusters Associated with Uncomplexed ISCU2  
The discovery of the HMWS material complicates kinetic analysis of enzymatic 
Fe-S cluster assembly using electronic absorption spectroscopy, as the mineral-like 
material and biological Fe-S clusters both exhibit sulfur-to-iron charge transfer bands 
that absorb in the 400-500 nm region. Further, simple desalting columns are ineffective 
at separating the Fe-S assembly complex and HMWS. In contrast, the 300-600 nm 
region of the CD spectrum is sensitive to the binding of [2Fe-2S] clusters to IscU,
40, 42, 44
 
whereas control mineralization reactions between ferrous or ferric iron with sulfide and 
DTT do not significantly contribute to this region of the spectrum (Figure 3.11). 
Alternate Fe-S assembly reaction conditions were also tested that minimize the  
 
Figure 3.10. Mössbauer spectra determined for the HMWS. SD Fe-S assembly reactions were 
performed under Standard conditions and applied to an anaerobic S-200 column, and then frozen for 
Mössbauer analysis. The Mössbauer showed supermagnetic properties at low temperature that 
collapsed into a central doublet at high temperature indicating a mineral. 
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generation of sulfide and Fe-S mineralization. The cysteine desulfurase activity is a 
direct measure of the sulfide generation ability of the Fe-S assembly complex. First, we 
explored Fe-S assembly reactions using the SDU complex, which is 10 fold less active 
than SDUF in the cysteine desulfurase reaction.
22
 Second, we tested alternate reductants 
that are less efficient at sulfide generation than DTT. The cysteine desulfurase activity of 
the SDUF complex is five-fold lower using 1 mM L-cysteine than with standard 
reactions with 100 µM cysteine and 4 mM DTT (data not shown).  
SDU Fe-S assembly reactions under Standard conditions result in competing 
[2Fe-2S] cluster formation and Fe-S mineralization pathways. The increased cysteine 
desulfurase activity for the SDUF complex (compared to SDU) under Standard 
conditions promotes Fe-S mineralization chemistry and may partially explain the ~25 
fold greater rate of increase in 456 nm absorbance, which is attributed to Fe-S 
 
Figure 3.11. [2Fe-2S] clusters, but not Fe-S minerals, exhibit significant CD signals. The CD 
spectra are overlaid for reaction of Fe(NH4)2(SO4)2 and Na2S (orange), FeCl3 and Na2S (red), 
Fe(NH4)2(SO4)2, Na2S, and DTT (blue), FeCl3, Na2S, and DTT (purple), Fe(NH4)2(SO4)2, Na2S, and 
cysteine (dark green), and FeCl3, Na2S, and cysteine (light green).  The ISCU2-Fe-S is displayed in 
black. 
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assembly.
22
 We show SDUF Fe-S assembly reactions under Standard conditions (above) 
generate the HMWS and spectroscopic features (Figure 3.1A and 3.2A) inconsistent 
with formation of a [2Fe-2S] cluster. In contrast, early time points for the SDU Fe-S 
assembly reaction revealed electronic absorption spectral features consistent with a [2Fe-
2S] cluster (Figure 3.12A). At later time points, [4Fe-4S]-like features dominated the 
spectra (Figure 3.12A) and resulted in features similar to the SDUF sample (Figure 
3.1A). The SDU sample, in contrast to SDUF, also exhibited a CD signal (Figure 3.12B) 
with peaks at 330 and 430 nm that are consistent with an [2Fe-2S] cluster bound to 
bacterial IscU.
44
 Together this data leads to a model in which (i) the increase in the 400-
500 nm electronic absorbance features are due to both [2Fe-2S] cluster and Fe-S cluster 
mineralization chemistry; (ii) the rate of mineralization is related to the ability of the 
complex to generate sulfide; and (iii) the competing Fe-S cluster mineralization 
chemistry overwhelms the [2Fe-2S] spectral features for the SDU sample at later time 
points (Figure 3.12A). To further test this model, we performed assays with an alternate 
reductant (L-cysteine) that is not as efficient at generating sulfide. 
 The SDU and SDUF Fe-S assembly complex samples generate [2Fe-2S] clusters 
under DTT-free conditions. The DTT-free Fe-S cluster assembly reaction includes 250 
M Fe2+ and 1 mM L-cysteine, which may function both as a substrate for generating 
sulfur and as a reductant to provide electrons for Fe-S cluster biosynthesis. The SDUF 
Fe-S assembly reaction exhibited different electronic absorbance spectra in the presence 
(Figure 3.12A) and absence (Figure 3.13A) of DTT. The final absorbance spectrum for  
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the SDUF DTT-free reaction had features consistent with a [2Fe-2S] cluster (Figure 
3.13A), rather than the peak at 400 nm that was attributed primarily to the HMWS. 
Measuring the SDUF Fe-S cluster formation rate under DTT-free conditions revealed the 
 
Figure 3.12. The SDU complex forms [2Fe-2S] clusters under in the presence of DTT. The SDU 
Fe-S assembly reaction was performed under Standard conditions. (A) The electronic absorbance 
spectra revealed [2Fe-2S] features (arrow at 456 nm) in early time points and a [4Fe-4S]-like 
peak (arrow at 400 nm) at later time points. The spectra were recorded 5, 10 30, and 60 minutes 
after initiating the reaction with L-cysteine. (B) The CD spectra revealed the development of 
characteristic [2Fe-2S] peaks. The spectra were collected at 0 (black), 20 (red), 40 (green), and 90 
(blue) minutes. 
 
Figure 3.13. Fe-S cluster formation for SDUF complex in the absence of DTT. (A) Final Fe-
S cluster absorbance spectrum and (B) kinetics monitored at 456 nm for reaction of SDUF 
(1:3:3 SD:ISCU2:FXN) with L-cysteine and Fe
2+
 under DTT-free conditions (see Methods).  
 
  65 
rate of Fe-S cluster formation (Figure 3.13B) was an order of magnitude slower than 
under Standard conditions (Figure 3.1B) and that the kinetic trace appeared to have a 
sigmoidal or lag phase of indefinite length (Figure 3.13B). We further interrogated the 
DTT-free Fe-S cluster assay using CD spectroscopy. Interestingly, both SDU (Figure 
3.14A) and SDUF (Figure 3.14B) samples exhibited CD features consistent with a [2Fe-
2S] cluster. Moreover, the [2Fe-2S] cluster CD signal intensity does not diminish at later 
time points, suggesting the [2Fe-2S] clusters are not converted to [4Fe-4S] clusters or 
other Fe-S species with different CD signals during the experiment. Since the [2Fe-2S] 
cluster could be bound either to the Fe-S assembly complex or to uncomplexed ISCU2, 
additional experiments were performed under Catalytic (1:60 NFS1:ISCU2) and 
Stoichiometric (1:1 NFS1:ISCU2) conditions. Increasing the concentration of 
uncomplexed ISCU2 was predicted to not change the CD signature if the [2Fe-2S] 
cluster was a stable intermediate bound to the assembly complex. In contrast, the CD 
spectrum showed a significant change for the Catalytic reaction (Figure 3.14C), but very 
little change for the Stoichiometric reaction (Figure 3.14D). Thus, there appears to be a 
correlation between the amount of uncomplexed ISCU2 and the intensity of the Fe-S CD 
signal. 
The SDUF Fe-S assembly complex generates non-protein Fe-S species under 
DTT-free conditions. Spectral comparisons for SDUF Fe-S assembly reactions under 
DTT-free conditions indicated the CD signal appeared to saturate after about 1 hour, 
whereas the electronic absorbance signal continued to increase at later time points 
(Figure 3.15A). This suggests at least two different Fe-S protein or small molecule  
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Figure 3.14. SDU and SDUF complexes generate [2Fe-2S] clusters in the absence of DTT. CD 
spectra measured for using DTT-free conditions with (A) SDU (1:3 SD:U), (B) SDUF (1:3:3 
SD:U:F), (C) Catalytic amount of SD (1:60:60 SD:U:F), and (D) Stoichiometric (1:1:3 SD:U:F) 
conditions. Time points are 0 (black), 20 (red), 40 (green), and 90 (blue) minutes after initiating 
the reaction with L-cysteine.  
 
 
Figure 3.15. SDUF Fe-S assembly reactions compared in the presence and absence of DTT. 
(A) In DTT-free conditions the kinetics are overlaid for the Fe-S assembly reactions  and the 
electronic absorbance at 456 nm (black) and CD at 430 nm (red) are shown.  (B) In Standard 
conditions the kinetics are overlaid for the Fe-S assembly reactions  and the electronic 
absorbance at 400 nm (black) and CD at 430 nm (red) are shown.  
 
  67 
species are being formed under these conditions. Quantitation of the final absorbance 
from the SDUF DTT-free Fe-S assembly reaction indicated a significantly higher 
concentration of [2Fe-2S] cluster (125 M) than ISCU2 (30 M), and that this reaction 
is limited by the amount (250 M) of iron (Table 3.1). Spiking a reaction that appeared 
complete with iron resulted in additional cluster synthesis (Figure 3.16). The non-protein 
bound Fe-S species may convert to the HMWS as even under DTT-free conditions the 
spectral properties for the SDUF reaction converted in a few hours from a characteristic 
[2Fe-2S] signal to features dominated by the absorbance signal previously assigned to 
the HWMS (Figure 3.17A). S-200 chromatographic analysis confirms HMWS formation 
after 3.5 hours (Figure 3.17B) that corresponds to the change in the absorbance spectra. 
These results revealed that the SDUF complex under DTT-free Fe-S assembly 
conditions generated (i) Fe-S species with CD parameters consistent with ISCU2 bound 
[2Fe-2S] clusters; (ii) additional Fe-S species with absorbance features consistent with 
[2Fe-2S] clusters that are not associated with ISCU2 (possibly bound to L-cysteine); and 
(iii) the slow conversion of the non-protein bound [2Fe-2S] clusters to HMWS.  
The SDUF complex generates [2Fe-2S] clusters on uncomplexed ISCU2. Here 
we combined Mössbauer spectroscopy with LC-ICP-MS analysis to confirm the 
molecular species (SDUF or uncomplexed ISCU2) that was associated with the [2Fe-2S] 
cluster. The LC-ICP-MS is a custom-designed system in which an FPLC is located in an 
anaerobic glovebox that splits the eluent after column chromatography between a UV-
Vis detector and ICP-MS. An SDUF Fe-S assembly reaction under Catalytic (no DTT) 
conditions was initiated by the addition of L-cysteine to a sample containing 
57
Fe, a  
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Figure 3.16. SDUF Fe-S assembly reactions are limited by iron in the absence of 
DTT.  The SDUF Fe-S assembly reactions appear to saturate under DTT-free 
conditions.  Addition of Fe
2+
 (arrow) results in additional Fe-S assembly.  
 
 
 
Figure 3.17.  (A) The SDUF Fe-S cluster assembly assay was measured under DTT-free conditions 
over the time course of 5 hours:  0min (black), 2 hrs (green), 3.5 hours (red), and 5 hours (blue).  
The [2Fe-2S] cluster-like feature seems to fade in to [4Fe-4S] cluster-like feature at later time 
points.  (B) An analytical S-200 monitored reaction similar to (A) was monitored for 1.5 hrs (black) 
and 3.5 hours (red).  The HMWS starts to form at the 3.5 hr mark indicated by shoulder between 10-
11 mL.  The small molecule thiols shows a weak 405 nm absorbance indicated by LMWS. 
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portion of the sample was placed in an anaerobic CD cuvette to monitor reaction 
progress, and the rest of the sample was desalted upon reaction completion to remove 
excess reagents before splitting the sample for LC-ICP-MS and Mössbauer analysis. A 
portion of the sample was applied to an anaerobic S-200 size exclusion column attached 
to the LC-ICP-MS.  The eluent from the column was partitioned between an ICP-MS to 
determine the iron concentration, and a UV-Vis detector to determine the absorbance at 
280, 400 and 456 nm. The iron counts along with the absorbance at all three wavelengths 
coincided primarily with the retention time of monomeric ISCU2, with some counts 
associated with SDUF (Figure 3.18). Mössbauer analysis revealed parameters (δ= 0.30 
mm/s and ΔEQ= 0.72 mm/s) consistent with a [2Fe-2S]
2+
 cluster with no significant 
population of free iron, [4Fe-4S] cluster, or Fe-S mineral (Figure 3.19), suggesting that 
the species on uncomplexed ISCU2 and the SDUF complex is a [2Fe-2S]
2+
 cluster. 
Together these data suggest a model in which [2Fe-2S]-SDUF intermediates undergo 
subunit dissociation or cluster transfer chemistry to generate uncomplexed [2Fe-2S]-
ISCU2 species in the absence of Fe-S target proteins.  
DTT Mediated [2Fe-2S] Cluster Conversion and Transfer Chemistry  
The SDUF complex generates [2Fe-2S] clusters that can be converted to [4Fe-4S] 
clusters by the addition of DTT. Spectral comparisons under Standard conditions 
(above) showed a rapid increase in the [4Fe-4S]-like HMWS absorbance signal that 
continues to increase at later time points, yet no significant CD signal due to an Fe-S 
species (Figure 3.15B). One possible explanation for the lack of a CD signal is that DTT 
facilitates the reductive coupling of two [2Fe-2S]
2+
 clusters to generate a CD silent [4Fe-
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4S]
2+
 cluster. To test this hypothesis, we determined if DTT can mediate conversion of 
ISCU2-bound [2Fe-2S] clusters to [4Fe-4S] species. A SDUF Fe-S assembly reaction 
was initiated under Catalytic (no DTT) conditions by the slow addition of 
57
Fe, 
incubated for an additional hour, the sample was split into two portions, and 50 mM 
DTT was incubated with one portion for an additional hour. Both portions were analyzed 
by LC-ICP-MS and Mössbauer spectroscopy. Samples with and without DTT exhibited 
retention times consistent with an ISCU2 monomer that coincides with the absorbance at 
all three wavelengths and with a small fraction (~10%) of the iron, whereas a larger 
fraction (~90%) of the iron associated with a low molecular weight species (LMWS) 
(Figure 3.20). The Mössbauer spectra for the sample without DTT revealed a strong 
signal (~90%) that was assigned based on its parameters (δ = 0.74 mm/s, ΔEQ = 3.4 
mm/s) to a high spin Fe(II) species coordinated to 4 thiol ligands, and weaker signals 
that correspond to high-spin Fe(II) bound to oxygen (δ = 1.3 mm/s, ΔEQ = 3.5 mm/s) and 
a [2Fe-2S]
2+
 cluster (δ = 0.3 mm/s, ΔEQ = 0.7 mm/s) (Figure 3.21). The LMWS from the 
S-200 column may correspond to the high-spin Fe(II) species ligated by the 10 mM L-
cysteine in the reaction mixture. The sample that included DTT exhibited Mössbauer 
features similar to the first sample except that a signal consistent with a [4Fe-4S]
2+
 
signal (δ = 0.4 mm/s, ΔEQ = 1.15 mm/s)  replaced the [2Fe-2S]
2+
 signal as the minor 
(~15%) fraction of the Mössbauer spectrum (Figure 3.21B). This result suggests a stable 
[2Fe-2S] monomeric species converts to a [4Fe-4S] cluster upon the addition of DTT. 
To further test this hypothesis, a SDUF Fe-S assembly reaction was performed under 
DTT-free conditions to generate a CD signal that corresponds to a [2Fe-2S] cluster, DTT  
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Figure 3.18. Formation of a [2Fe-2S]
2+
 cluster bound to uncomplexed ISCU2.  An SDUF Fe-S 
assembly reaction was performed under catalytic condition and applied to an anaerobic S-200 
column in which the eluent was split to determine iron counts by ICP-MS. The majority of the iron 
counts coeluted with uncomplexed ISCU2 (16 mL).  
 
Figure 3.19. Formation of a [2Fe-2S]
2+
 cluster bound to uncomplexed ISCU2.  An SDUF Fe-S 
assembly reaction was performed under catalytic condition and was frozen for Mössbauer 
analysis.  The quadruple doublet was fit (red) with parameters δ = 0.30 mm/s and ΔEQ = 0.72 
mm/s. 
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was added, and the CD spectra was followed as a function of time. This experiment 
revealed a DTT-dependent loss of Fe-S cluster CD signal until only the features from the 
PLP cofactor remained (Figure 3.22). The loss of the ISCU2-[2Fe-2S] signal could be 
due to conversion to a CD-silent [4Fe-4S] cluster, consistent with Mössbauer data 
(Figure 3.21), or transfer of the [2Fe-2S] cluster to DTT and generation of a CD silent 
species. Although this cluster conversion/transfer process is reproducible, the rate varies 
with some unknown factor (see Discussion). Interestingly, adding DTT at the beginning 
of the experiment resulted in HMWS Mössbauer features, whereas adding DTT after 
[2Fe-2S] cluster formation resulted in Mössbauer features consistent with a [4Fe-4S] 
cluster. Together, these data reveal that DTT can release sulfide from the Fe-S assembly 
complex that initiates Fe-S mineralization chemistry, can induce the conversion of  
 
Figure 3.20. Formation of a [2Fe-2S]
2+
 cluster bound to uncomplexed ISCU2.  An SDUF Fe-S 
assembly reaction was performed under catalytic condition and applied to an anaerobic S-200 
column in which the eluent was split to determine iron counts (black) by ICP-MS and absorbance 
at 280 (red, scaled down 10 fold for overlay), 400 (green), and 456 (blue) nm. (A) The 
chromatogram was cropped to highlight the uncomplexed ISCU2 that elutes at 16 mL.  (B) 
Additional low molecular weight species (LMWS) eluted at 21-23 mL that contained >90% of the 
iron. 
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ISCU2-bound [2Fe-2S] clusters to [4Fe-4S] clusters, and may also be able to function in 
cluster transfer reactions as an acceptor molecule (similar to L-cysteine, above).   
DTT mediates transfer of [2Fe-2S] clusters from ISCU2 to apo FDX. Here CD 
spectroscopy was used to monitor the transfer of Fe-S clusters generated by the SDUF 
complex under Acceptor (no DTT) conditions to apo FDX. Surprisingly, including  
 
Figure 3.21. Mössbauer spectra determined for the ISCU2 monomer under catalytic conditions. 
Samples were prepared anaerobically (see Methods) under DTT-free conditions.  (A) Half the 
sample was frozen for Mössbauer analysis where ~4% was [2Fe-2S]
2+
 cluster (δ= 0.3 mm/s, 
ΔEQ=0.7 mm/s; indicated by arrows) and 90% was high-spin Fe(II) bound to sulfur with 4 
coordinate thiol ligation (δ= 0.74 mm/s, ΔEQ=3.4 mm/s) and remaining 6% was unreacted high-
spin Fe(II) bound to oxygen (δ= 1.3 mm/s, ΔEQ=3.5 mm/s). (B)The other half of the sample 
was treated with 10 mM DTT and then frozen for Mössbauer analysis where 15% was [4Fe-
4S]
2+
 cluster (δ= 0.4 mm/s, ΔEQ=1.15 mm/s; indicated by arrows) and 85% was high-spin Fe(II) 
bound to sulfur with 4 coordinate thiol ligation (δ= 0.74 mm/s, ΔEQ=3.4 mm/s).  
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excess apo FDX in the assembly assay did not alter the Fe-S CD features and the same 
peaks developed at 330 and 430 nm (rate of 0.055 min
-1
, Figure 3.23) that were 
previously assigned to ISCU2-bound [2Fe-2S] clusters (Figure 3.24A). The addition of 
DTT at the end of the reaction resulted in a slow change (rate of 0.02 min
-1
; Figure 
3.23B) in the CD features from those characteristic of the [2Fe-2S]-ISCU2 to features 
consistent with reduced FDX
114
 (Figure 3.24B). Addition of DTT and apo FDX at the 
start of the Fe-S assembly reaction resulted in a fairly rapid (rate of 0.10 min
-1
; Figure 
3.23C) generation of the [2Fe-2S]
1+
-FDX signal and no evidence for a [2Fe-2S]-ISCU2 
intermediate species (Figure 3.24C). These data indicate the SDUF complex generates 
[2Fe-2S] species that can be transferred to thiol-containing acceptor molecules and that  
 
Figure 3.22.  The SDUF Fe-S cluster assembly was monitored using CD under DTT-free 
conditions.  Once the [2Fe-2S]-ISCU2 feature reached saturation (black), 4 mM DTT was added 
and at 2 min (red) or 5 min (green) the [2Fe-2S]-ISCU2 faded and all that was observed was the 
PLP from NFS1 (green).  This indicated that ISCU2 transferred the cluster to DTT, and 
mineralization may have started to occur. 
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Figure 3.23. SDUF Fe-S cluster transfer reactions to apo FDX. The SDUF Fe-S assembly reactions were 
performed under Acceptor conditions (see Methods) that included apo FDX.  (A) The cluster assembly 
reaction was initiated by L-cysteine in the absence of DTT and the CD spectrum was monitored for 130 
minutes and fit to an exponential rise equation to yield a rate 0.055 min
-1
. (B) After the reaction from (A) 
was complete, DTT was added and CD spectra were measured for 90 minutes which measured a rate of 
0.022 min
-1
. (C) The same reaction as (A) was performed in the presence of DTT.  Rate was 0.10 min
-1
. 
The Ellipticity was measured at 330 nm. 
 
Figure 3.24. SDUF Fe-S cluster transfer reactions to apo FDX. The SDUF Fe-S assembly reactions 
were performed under Acceptor conditions (see Methods) that included apo FDX.  (A) The cluster 
assembly reaction was initiated by L-cysteine in the absence of DTT and the CD spectrum was 
monitored at 0 (black), 20 (red), 40 (green) and 90 (blue) minutes. (B) After the reaction from (A) 
was complete, DTT was added and CD spectra were obtained at 0 (black), 20 (red), 40 (green), and 
90 (blue) minutes. (C) The same reaction as (A) was performed in the presence of DTT.  CD spectra 
were recorded at 0 (black), 10 (red), 20 (green), and 40 (blue) minutes. 
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DTT has a complex role in Fe-S assembly reactions that includes generating sulfide for 
Fe-S mineralization chemistry, facilitating [2Fe-2S] cluster to [4Fe-4S] cluster 
conversion, mediating [2Fe-2S] cluster transfer chemistry, and potentially functioning as 
an cluster acceptor.  
Discussion 
Experiments to identify reaction intermediates and elucidate mechanistic details 
of biosynthetic pathways often rely on monitoring reaction progress with kinetic 
measurements. This is challenging for Fe-S cluster biosynthesis as the substrates (iron, 
cysteine, and electrons) also undergo competing non-enzymatic Fe-S mineralization and 
self-assembly chemistry, plus the synthesized Fe-S clusters are capable of undergoing 
ligand exchange reactions. These competing reactions and chemistry have complicated 
the interpretation of results and limited mechanistic insight. It is therefore important to 
elucidate factors that partition reaction intermediates between these competing pathways 
and understand the types and properties of Fe-S species that are being generated. Here 
we identify conditions that favor pathways that compete with Fe-S cluster biosynthesis, 
uncover details of the surprisingly complex DTT-mediated chemistry for in vitro assays, 
and provide insight into human Fe-S cluster biosynthesis. 
Fe-S assembly reactions under Standard in vitro assay conditions generate both 
Fe-S clusters by the assembly complex and a HMWS that has properties consistent with 
a solubilized Fe-S mineral. The HMWS is an iron, sulfide, and thiol-containing-protein 
dependent material that exhibits Mössbauer parameters (δ = 0.35 mm/s and ΔEQ = 0.67  
  
  77 
 
mm/s) similar to that of Fe-S minerals, such as pyrite (δ = 0.25-0.43 mm/s and ΔEQ = 
0.61-0.66 mm/s)
115
, or superparamagnetic behavior consistent with mineral-like 
materials (Figure 3.10). The HMWS forms in the absence of the Fe-S catalytic subunit 
ISCU2 (Figures 3.6 and 3.25A) and can participate in the chemical reconstitution of apo 
target proteins (Figures 3.4 and 3.25B). In DTT-free conditions, both SDU and SDUF 
samples produce species with electronic absorbance and CD spectroscopic properties 
consistent with a [2Fe-2S] cluster (Figures 3.13 and 3.14). The partitioning between 
HMWS and [2Fe-2S] cluster biosynthetic pathways appears to be shifted toward the 
HMWS for SDUF compared to SDU samples, and for DTT compared to DTT-free assay 
conditions. SDUF is a more active cysteine desulfurase in vitro and DTT is more 
efficient at sulfide production than cysteine, suggesting increased HMWS formation 
(Figure 3.25C) relative to [2Fe-2S] cluster synthesis (Figure 3.25D) may at least 
 
Figure 3.25. Model for competeing Fe-S cluster biosynthesis and mineralization pathways. (A) 
minealization of SD complex to generate HMWS. (B) Chemical reconstitution of apo FDX. 
Competing mineralization (C) and Fe-S biosynthetic (D) pathways for the SDU and SDUF 
complexes. Transfer of [2Fe-2S] cluster from the assembly complex to (E) apo FDX, (F) 
uncomplexed ISCU2, and (G) free thiol-containing molecules.  The [2Fe-2S]-ISCU2 species can (H) 
transfer the cluster to apo FDX in a DTT mediate process and (I) reductive couple to generate [4Fe-
4S]-ISCU2 species. (J) The [2Fe-2S] cluster bound to small molecule thiols can also slowly convert 
to HMWS. Protein complexes are displayed in red and iron-containing species in blue.  
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partially depend on the ability of a persulfide intermediate to be intercepted (by DTT 
and/or cysteine) and produce sulfide. Chemical reconstitution reactions for [4Fe-4S]-
containing radical SAM enzymes generate a HMWS with similar spectroscopic 
properties.
113
 Deconvoluting the enzymatic and mineralization processes is challenging 
as they exhibit comparable formation kinetics (both depend on cysteine turnover by 
NFS1), overlapping electronic absorbance properties, and the products coelute on 
desalting columns. 
Fe-S cluster assembly assays under DTT-free conditions revealed [2Fe-2S]-
cluster intermediate species. Mössbauer spectroscopy indicated [2Fe-2S] clusters were 
formed under cysteine-reducing (DTT-free) conditions (Figure 3.19). Fe-S assembly 
assays under similar conditions revealed the concurrent development of electronic 
absorbance and CD spectroscopic signals (Figures 3.13-3.15) and a concentration of 
[2Fe-2S] clusters that is significantly greater than the total ISCU2 concentration (Table 
3.1). We suggest formation of both [2Fe-2S]-ISCU2 (Figure 3.25F) and [2Fe-2S]-X 
(Figure 3.25G) species, where X is a small molecule such as cysteine (in this reaction), 
DTT, or GSH. As [2Fe-2S]-GSH complexes do not exhibit significant Fe-S CD signals 
(Figure 3.11), we suspect [2Fe-2S] clusters bound to small molecule thiols like cysteine 
or DTT are also CD silent. At later time points the absorbance signal continues to 
increase and then slowly changed (> 2 hours) to a signal with HMWS rather than [2Fe-
2S] features (Figure 3.17). In contrast, the CD signal plateaus (Figure 3.15A). This 
suggests a model in which cluster assembly on the complex is slow under cysteine-
reducing conditions and readily and concurrently generates [2Fe-2S] clusters on ISCU2 
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(contributing to CD and absorbance properties) and cysteine (contributing primarily to 
absorbance properties), and that at longer time points the [2Fe-2S] bound to cysteine is 
slowly converted to the HMWS (Figure 3.25J). A model in which the SDUF complex 
generates a labile [2Fe-2S] cluster is further supported by the observations that the Fe-S 
CD signal intensity is proportional to the amount of excess ISCU2 that is added to the 
reaction (Figure 3.14) and LC-ICP-MS data that indicates most of the Fe-S species are 
associated with uncomplexed ISCU2 (Figures 3.18 and 3.20). This model is also 
consistent with the fact that IscU variants that are compromised in cluster transfer 
(D37A in E. coli), but not native IscU complexes, copurify with [2Fe-2S] clusters bound 
at the active site
47, 53
. It is unclear if ISCU2 subunits dissociate upon cluster formation or 
if the [2Fe-2S]-SDUF complex transfers clusters to uncomplexed ISCU2 through a 
ligand exchange mechanism.  
We identified five different roles for DTT in Fe-S assembly reactions. First, DTT 
is commonly added as a surrogate electron donation system. Ferredoxin-ferredoxin 
reductase is thought to be the physiological electron donation system, but is not typically 
used in Fe-S assays because the absorbance and CD properties of ferredoxin, ferredoxin 
reductase, and NADPH complicate the ability to monitor cluster synthesis. Second, DTT 
is very effective at cleaving cysteine-persulfide intermediates and generating sulfide, 
which can undergo mineralization chemistry (Figure 3.25C). SDUF Fe-S assembly 
assays that include DTT rapidly generate HMWS absorbance features and are CD silent 
(Figure 3.15B). A simple explanation for this observation is that the SDUF complex 
exclusively partitions towards the mineralization (Figure 3.25C) rather than biosynthesis 
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(Figure 3.25D) pathway. This explanation would necessitate a correlation for the rates of 
the cysteine desulfurase and Fe-S assembly reactions. Recent results reveal Fe-S 
assembly complexes with ISCU2 variants (SDUC35AF and SDUC61AF) exhibit native like 
cysteine desulfurase activities, but compromised Fe-S cluster assembly reactions 
(Chapter II). We therefore hypothesize that the addition of DTT at the beginning of the 
experiment results in both mineralization (Figure 3.25C) and biosynthetic cluster 
formation (Figure 3.25D), and that the third role of DTT is as a [2Fe-2S] cluster acceptor 
(Figure 3.25G) that can generate HMWS (Figure 3.25J). This hypothesis suggests the 
previously characterized SDUC35AF and SDUC61AF complexes undergo the 
mineralization pathway (explaining the slow increase in absorbance), but the 
biosynthetic route (Figures 3.25D, 3.25G, and 3.25J) to HMWS is compromised. Fourth, 
we show DTT addition results in the conversion of [2Fe-2S]-ISCU2 to [4Fe-4S]-ISCU2 
species (Figures 3.21 and 3.25I). This type of reductive coupling has precedent in both 
biomimetic
3
 and IscU literature
48
. The last role for DTT is in mediating the transfer of 
Fe-S clusters to apo FDX. Surprisingly, reactions that include apo FDX but no DTT 
generate [2Fe-2S]-ISCU2 species and transfer only occurs upon the addition of DTT 
(Figures 3.24 and 3.25H). It is unclear if DTT is required to reduce the cluster for 
transfer (the resulting holo-FDX appears to be reduced based on the CD spectra) or if 
DTT functions through a ligand exchange mechanism. Interestingly, the kinetics of 
cluster transfer from [2Fe-2S]-ISCU2 to apo FDX are much slower than the kinetics of 
cluster assembly and transfer using the SDUF complex, suggesting either the chemical 
reconstitution is faster than the enzymatic process and/or [2Fe-2S]-ISCU2 is not an 
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intermediate and is bypassed in cluster assembly on FDX (Figure 3.25E). Together, DTT 
appears to have in vitro roles in Fe-S assembly assays as a reductant, in persulfide 
cleavage, in [2Fe-2S] to [4Fe-4S] cluster conversion, in mediating [2Fe-2S] cluster 
transfer to apo FDX, and as a [2Fe-2S] cluster ligand.  
 
Conclusion 
In summary, we provide details of competing pathways for Fe-S cluster 
biosynthesis and Fe-S mineralization. Our data suggest a labile [2Fe-2S] cluster is 
generated on the native SDUF complex that can be transferred to thiol-containing 
acceptor molecules. Notably, this labile [2Fe-2S]-SDUF model is inconsistent with the 
proposal that mammalian Fe-S assembly complex forms a stable [4Fe-4S] species.
62
 
This stable [4Fe-4S]-SDUF proposal would also be inconsistent with the apparent 
requirement of additional protein factors in [4Fe-4S] cluster synthesis.
116
 Moreover, 
even though our data supports a transient [2Fe-2S] intermediate on the SDUF Fe-S 
assembly complex, it does not rule out the possibility that additional protein factors 
affect the stability of Fe-S clusters on the assembly complex. Overall, the multiple roles 
for DTT complicate the interpretation of in vitro Fe-S assembly results and necessitate 
the development of new functional assays that monitor the kinetics of Fe-S cluster 
reactions using the native electron donation system and the ability to monitor Fe-S 
cluster assembly in an assay mixture with many different electronic absorbance and CD 
active chromophores. 
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CHAPTER IV 
ALANINE SCANNING OF THE FRATAXIN (FXN) SURFACE IDENTIFIES A 
HOTSPOT FOR BINDING AND ACTIVATION WITH THE SDU COMPLEX 
 
Introduction 
 Defects in the frataxin (FXN) protein have been shown to cause the 
neurodegenerative disease Friedreich’s Ataxia (FRDA), a progressive degenerative 
disease of children and adolescents that ultimately leads to premature death. 
88, 117, 118
  
Large research efforts to define the function of FXN and develop therapeutic approaches 
for the treatment of FRDA have been launched since the discovery of the link between 
FRDA and the FXN gene in 1996. Unfortunately, these efforts have not resulted in an 
effective FRDA therapy and the disease symptoms are often simply managed through 
chelation therapy to restrict mitochondrial iron accumulation and antioxidant treatment 
to limit ROS damage in patients. 
119, 120
  Although many roles have been proposed for 
the FXN family of proteins, emerging evidence suggests a regulatory role in Fe-S cluster 
biosynthesis. 
22, 89, 121, 122
  FXN is required to interact with the Fe-S cluster biosynthesis 
machinery to perform such a regulatory function. As mutations that decrease these 
protein-protein interactions might be linked to FRDA, it is essential to define these 
interactions both in terms of identifying FXN binding partners and also which residues 
on those proteins contribute to frataxin-based regulation.  
 Immunoprecipitation and pull-down assays by Cortopassi and coworkers suggest 
FXN interacts with the core components of the human Fe-S cluster assembly system  
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NFS1-ISD11 and ISCU2; as well as with the chaperones GRP75, HSP60, and HSC20. 
123, 124
  Many of these protein-protein interactions have been confirmed by others in the 
yeast and E. coli Fe-S cluster assembly systems. 
125-127
  We have shown a functional four 
protein complex between NFS1-ISD11, ISCU2, and FXN (named SDUF), which 
provides validation to the role of FXN in Fe-S cluster biosynthesis. 
22, 62, 80
  Taken 
together these results suggest that FXN interacts with a preformed NFS1-ISD11/ISCU2 
(SDU) complex, and interaction of FXN with this complex significantly increases the 
rate of the cysteine desulfurase and Fe-S cluster assembly on the scaffold protein. Small-
angle X-ray scattering data and structural analysis of the analogous E. coli 
IscS/IscU/CyaY complex (IscS, IscU, and CyaY are homologs of human NFS1, ISCU, 
and FXN, respectively) suggests that CyaY binds near the dimer interface of the cysteine 
desulfurase IscS, while the scaffold protein IscU binds near the periphery of the IscS 
dimer. 
128
  This arrangement not only allows for interaction of IscS with CyaY and IscU, 
but also allows for interaction between IscU and CyaY.  
 Several attempts have been made to identify residues involved in the interaction 
between FXN and either the intact SDU complex or components of the SDU complex. 
Based on pull-down assays Cortopassi et al suggest an interaction between FXN and 
ISD11 that is mediated through FXN residue I154 in the presence of nickel. 
124
  
Mutation of the basic residues R220E/R223E/R225E on IscS or the acidic residues 
E18K/E19K/E22K on CyaY have been shown to disrupt the interaction of these two 
proteins, suggesting that the acidic ridge of the frataxin family serves as the binding 
surface for the cysteine desulfurase. 
128
  Further protein-protein interactions were 
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observed by Stemmler et al, who demonstrated that several residues on yeast Yfh1 are 
perturbed upon addition of the yeast scaffold protein Isu1. 
129
  Pull-down assays of yeast 
Yfh1 variants including N122K (human FXNN146K), N122A/K123T/Q124A (human 
FXNN146K/K147T/Q148A), and W131A (human FXNW155A), suggest that the β-sheet region of 
the protein is involved in interactions with the yeast scaffold protein Isu1 and that W131 
(human FXNW155) is a hotspot for interaction. 
125, 126
   Furthermore in vivo studies of 
yeast Yfh1 by Foury et al suggest that Q129 (human FXNQ153), W131 (human 
FXNW155), and R141 (human FXNR165) form a cluster of functionally important residues 
on the FXN surface, which could facilitate protein-protein interactions. 
125
  Puccio et al 
used pull-down assays of 15 FXN variants (Y95G, E96K, D104G, E108K, E111K, 
D115K, D122Y, D124K, G130V, N146A, N146K, I154F, W155A, W155R, & W173G) 
in the context of the SDU complex and further confirmed and expanded upon the results 
seen in yeast and E. coli; identifying six variants (E108K, E111K, D124K, N146K, 
W155A and W155R) that disrupted or abolished the FXN/SDU interaction. 
80
  The 
negatively charged acidic patch residues E108, E111, and D124 are suggested to interact 
with the basic residues on NFS1-ISD11, while the N146 and W155 β-sheet residues are 
proposed to interact with ISCU2. Furthermore the complete loss of interaction between 
SDU and the W155R variant or the less severe W155A variant support the findings in 
yeast that this residue is critical for interaction with ISCU2.
86, 87
  The available 
biochemical, structural, and pull-down assay data suggest regions of the FXN β-sheet 
and α1 helix, which appear to be important in protein-protein interactions with SDU. 
Here we build upon these results to examine the FXN side-chain contributions for 
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binding to the SDU complex and also establish the functional importance of FXN side-
chains for the activation of the Fe-S assembly complex. These experiments provide vital 
information towards the design of peptide mimics as a FXN replacement strategy and 
potential FRDA therapeutic. 
Experimental Procedures 
Protein Preparation 
 All mutations were introduced into a pET11a plasmid containing a codon 
optimized human FXN gene (FXN Δ1-55), lacking the first 55 amino acids, using the 
QuikChange method (Stratagene). 
22
  Presence of the mutation was confirmed by DNA 
sequencing, performed by the Texas A&M University Gene Technology Laboratory. 
The plasmids containing each mutant were transformed into E. coli BL21(DE3) 
competent cells and grown at 37 °C, until an OD600 of ~0.7 was obtained. Protein 
expression was then induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG), and cells were incubated at 16 °C for 16 hours. The cells were then harvested by 
centrifugation and lysed by sonication (Branson Sonifier 450) in 50 mM Tris pH 7.5. 
The supernatant was loaded onto an anion exchange column (26/20 POROS 60HQ, 
Applied Biosystems) and eluted with a linear gradient from 0 to 800 mM NaCl in 50 
mM Tris pH 7.5. The fractions corresponding to monomeric frataxin were collected, 
concentrated, and loaded onto a Sepharcyl S100 (26/60, GE Healthcare) size exclusion 
column equilibrated with 50 mM HEPES, 150 mM NaCl pH 7.5. Protein concentrations 
for each variant were calculated using their absorbance at 280 nm with an extinction 
coefficient of 26030 M
-1
cm
-1
 used for all variants, except Y118A and W155A (ε = 
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24750 M
-1
cm
-1 and ε = 20340 M-1cm-1, respectively).130  The ISCU2 and NFS1-ISD11 
proteins were purified as previously described and their protein concentrations 
determined using extinction coefficients of 10,900 M
-1
cm
-1
 (PLP) and 8250 M
-1
cm
-1
 at 
wavelengths of 420 nm and 280 nm, respectively.
22, 130
 
Cysteine Desulfurase Activity Measurements 
  The number of equivalents of each FXN variant required to saturate the cysteine 
desulfurase activity was determined by titrating increasing amounts of each FXN variant 
into a standard reaction mixture, as previously described with a final volume of 800 μL. 
22, 86, 107, 108, 131
  Once the saturating about of each variant was determined reaction 
mixtures containing 0.5 μM NFS1-ISD11 (SD), 1.5 μM ISCU2, the saturating amount of 
FXN (or FXN variant), 10 μM pyridoxal-5’-phosphate (PLP), 2 mM dithiothreitol 
(DTT), 5 μM Fe(NH4)2(SO4)2, and 50 mM Tris, 250 mM NaCl pH 8.0 were incubated 
for 30 minutes in an anaerobic glovebox at ~14 °C. 
22
  The cysteine desulfurase reaction 
was initiated with the addition of 100 μM L-cysteine at 37 °C, and quenched with 100 
μL each of 20 mM N,N-dimethyl-p-phenylenediamine in 7.2 N HCl and 30 mM FeCl3 in 
1.2 N HCl. Following 20 minute incubation at 37 °C and centrifugation for 5 minutes at 
12,000 rpm, the methylene blue formation was measured at 670 nm and converted to 
sulfide production using a Na2S standard curve. The rate is expressed in units of mol 
sulfide per mol SD per minute at 37 °C.  
Michaelis-Menten Kinetics for Frataxin Variants in SDUF Complex 
 To a standard reaction mixture of 0.5 μM (SD), 1.5 μM ISCU2, 10 μM 
pyridoxal-5’-phosphate (PLP), 2 mM dithiothreitol (DTT), 5 μM Fe(NH4)2(SO4)2, and 
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50 mM Tris, 250 mM NaCl pH 8.0 was added the saturating amount of the FXN 
variants. 
86, 131
  Reactions were incubated for 30 minutes in an anaerobic glovebox before 
being initiated with the addition of 12.5 - 1000 μM L-cysteine. The rate of cysteine 
desulfurase activity was analyzed as above. The reaction rates were plotted verses L-
cysteine concentration and fit with the Michaelis-Menten equation in KaleidaGraph. The 
kcat was determined at varying FXN concentrations and used to determine the binding 
constant of FXN to the SDU complex using a weighted fit in Kaledagraph determined 
from kcat error or replications. These results were fit as a type II allosteric activator using 
Eq. 4.1 in KaleidaGraph, where the [SDUF] is calculated as shown in Eq. 4.2.    
Alternatively, the rate was plotted verses [FXN] and also fit to the quadratic Eq. 4.2 and 
showed similar kcat and Kd values. 
             
                  
 
 
 
(Eq. 4.1) 
 
 
(Eq. 4.2) 
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Labeling of R97A FXN at Residue S202C for Fluorescence Anisotropy Measurements 
Purified R97A, S202C FXN in 50 mM HEPES pH 7.5, 150 mM NaCl was 
aerobically combined with a 3-fold molar excess of 20 mM Texas Red
®
 C2 maleimide 
(Life Technologies) dissolved in DMSO. The labeling was allowed to proceed for 
approximately 3 days in a dark eppendorf tube at room temperature, and the excess 
fluorophore was removed by a 1 mL anion column (HiTrap
TM
 Q HP) using 50 mM 
HEPES pH 7.5 for an extended wash of 50 mL before starting a linear salt gradient from 
0-500 mM NaCl over a 50 mL time course. Labeled FXN elutes between 150-300 mM 
NaCl. The labeling efficiency of R97A FXN was estimated at 40 %, by dividing the 
absorbance due to the fluorophore at 596 nm (Texas Red ε596 = 85,000 M
-1
cm
-1
)(Life 
Technologies) by the absorbance at 280 nm due to FXN (native FXN ε280 = 26,030 M
-
1
cm
-1
) and confirmed by a Bradford assay. 10 nM of labeled native FXN (FXNTX)  was 
anaerobically combined with 20 µM ISCU2 in buffer A and varied concentration of SD 
from a 30 µM stock solution of NFS1-ISD11 (SD), and 2 mM DTT to a total volume of 
0.4 mL in a 1 mL anaerobic cuvette, and the cuvette was sealed and parafilmed. Each 
sample was prepared separately in an anaerobic glovebox, to keep the FXN 
concentration constant and centrifuged for 20 min. The fluorescence spectra was 
measured with a Fluoromax4 fluorimeter (Horiba Jovin-Yvon) at 16 C. Fluorescence 
was measured using an excitation wavelength of 587 nm, an emission wavelength of 618 
nm, a signal integration time of 30 s for 300 s, and slit width of 10 nm.  
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Results 
Residues of the β-sheet Impair Interactions with the Fe-S Cluster Assembly Complex   
A total of 39 alanine or glycine (used for proline residues) point variants were 
expressed in E. coli and purified to >95% homogeneity. During the protein purification 
process the Δ1-55 FXN construct spontaneously truncated to produce the mature 
(FXN
81-210
) form of the protein. 
132
  The number of equivalents necessary to saturate the 
cysteine desulfurase activity for each variant was determined by maximum activity that 
no longer increases with the addition of more FXN variants.  Michaelis-Menten 
parameters for all of the alanine scanning variants were determined (Table 4.1). The 
Michaelis-Menten parameters kcat and KM were determined, using the cysteine 
desulfurase activity at saturating FXN variant levels. The binding constants for all 
alanine scanning variants were determined by plotting the kcat verses FXN variant 
concentration or NFS1 activity verses FXN variant and fitting the data with Eq. 4.2. The 
kcat varied depending on batch on NFS1 and activity of that batch, the relative activity 
was used to standardize each batch for comparison of the different variants. The 
Log(activity) verse Log (Kd) was used to determine which variants affected activity and 
which affected binding (Figure 4.1A). Most of the variants were similar to wild type 
FXN or exhibited weaker binding as shown in orange (100 fold weaker binding than 
wild type) and red (1000 fold weaker binding than wild type). The red variants W155A 
and R165A and blue Q153A were significantly weaker binding than all other variants, 
which were modeled on Figure 4.1B to show a hotspot. In blue, Q148 and Q153A were 
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both affected weaker binding and were only variants that had a significant decrease in 
activity.  
 
 
Figure 4.1. (A) The Log (activity) vs. Log (Kd). The variants that are severely affected in 
binding are colored in red, and modestly affected in binding colored in orange. In blue both 
activity and binding were affected. The wild type is in green. (B) Using PDB code: 1EKG all the 
mutants that were made are represented as sticks and were color coded according to (A). 
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Table 4.1. Kinetic Parameters for SDU with FXN Alanine Scanning Variants 
Protein Activity (min
-1
) Km
Cys
 (mM) kcat/Km (M
-1
 s
-1
) Kd (µM) 
SDUF* 10.0 0.018 8981 0.09 ± 0.03 
H86A* 7.7 0.015 12311 0.04 ± 0.01 
D91A* 9.6 0.017 13614 0.02 ± 0.02 
E92A* 11.7 0.018 15392 0.14 ± 0.04 
E96A* 10.3 0.019 13019 0.47 ± 0.07 
R97A* 10.1 0.018 15000 0.24 ± 0.07 
E100A* 8.4 0.014 8322 0.02 ± 0.01 
E101A* 10.9 0.025 7158 0.94 ± 0.12 
D104A* 10.9 0.026 6850 0.45 ± 0.06 
S105A 8.1 0.019 6013 0.02 ± 0.01 
L106A 9.5 0.020 6740 0.20 ± 0.06 
E108A* 9.0 0.020 7176 0.34 ± 0.04 
E111A* 9.3 0.017 7558 0.24 ± 0.05 
D112A* 14.6 0.030 7905 0.71 ± 0.10 
D115A 10.6 0.019 9057 0.20 ± 0.04 
K116A 11.1 0.032 4892 0.04 ± 0.03 
P117G 8.0 0.020 5690 0.10 ± 0.03 
Y118A 8.8 0.028 4468 0.07 ± 0.03 
T119A 9.7 0.021 6534 0.08 ± 0.03 
E121A* 8.3 0.010 11722 0.06 ± 0.03 
D122A* 7.8 0.015 7392 0.04 ± 0.02 
D124A* 7.8 0.016 7887 2.44 ± 0.20 
S126A 8.6 0.021 5768 0.02 ± 0.03 
V131A 6.8 0.023 4746 0.13 ± 0.03 
T133A 9.5 0.021 7325 0.42 ± 0.10 
K135A 8.1 0.021 5448 0.05 ± 0.03 
T142A 11.3 0.026 6134 0.81 ± 0.19 
V144A 8.1 0.021 6270 0.18 ± 0.05 
N146A 6.1 0.019 5213 1.37 ± 0.18 
Q148A* 3.3 0.012 7277 1.17 ± 0.58 
P150G 9.0 0.014 10384 1.62 ± 0.22 
N151A 7.3 0.027 4367 0.58 ± 0.08 
Q153A
*
 3.3 0.014 6231 12.45 ± 4.62 
W155A* 7.9 0.012 17639 22.72 ± 2.38 
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Table 4.1. Kinetic Parameters for SDU with FXN Alanine Scanning Variants Continued 
Protein Activity (min
-1
) Km 
Cys
 (mM) kcat/Km (M
-1
 s
-1
) Kd (µM) 
S157A 7.9 0.018 7071 0.33 ± 0.05 
P163G 9.3 0.018 8379 2.27 ± 0.23 
R165A 12.0 0.020 9708 44.28 ± 6.21 
D167A 7.9 0.020 6407 0.16 ± 0.04 
H177A 7.4 0.020 6017 0.02 ± 0.01 
D178A 10.5 0.025 5937 0.41 ± 0.11 
L190A 12.0 0.026 6542 0.17 ± 0.06 
K195A 9.1 0.025 5184 0.02 ± 0.02 
 
 
 
 
Discussion 
 Protein-protein interactions between FXN and the SDU complex have been 
demonstrated in the yeast, E. coli, and human systems; where interactions with ISCU 
and NFS1-ISD11 are proposed to occur through the FXN β-sheet and α1-helix, 
respectively. 
22, 80, 86, 124-126, 129, 131, 133
  However, only limited information is known about 
the specific residues of interaction and the kinetic implications of these interactions. 
While attempts have been made to identify residues involved in the FXN/SDU 
interaction through loss of SDU pull-down or NMR amide backbone perturbation 
analysis, to our knowledge this is the first attempt to assess the functional importance of 
individual FXN residues to map the surface of interaction using the SDU complex in 
vitro.  
 Examination of the kinetic parameters of the 39 FXN variants suggests a hotspot 
for FXN interaction with SDU through the β sheet. Combination of alanine scanning 
with functional assessment through the cysteine desulfurase assay, identified 12 residues 
  * Indicates the experiment was performed by Nicholas Fox 
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of the FXN α1 helix and β-sheet with significantly to moderate decrease in SDU binding 
and of those 12, 2 residues significantly affectedthe ability for  FXN to activate NFS1. 
Drastic binding defects were observed upon mutation of the FXN residues Q153, W155, 
and R165 to alanine, while moderate impairment was seen for nine FXN residues (E101, 
D112, D124, T142, N146, Q148, P150, N151, and P163) of the α1 helix and β-sheet 
regions (Figure 4.1, Table 4.1). Significant activation defects of the SDU complex were 
found upon mutation of two residues (Q148 and Q153) of the FXN β-sheet (Figure 4.1, 
Table 4.1). Impairment of the binding and/or activation of the FXN residues N146, 
Q148, Q153, W155, and R165 is consistent with previous findings by Barondeau et al.
86, 
122
  Furthermore pull-down assays in the yeast and human system support the findings 
that W155 and N146 are important for SDU interaction. 
80, 125, 126
  The NMR studies of 
Stemmler et al, showing perturbation of FXN residues Q148 and N151 in the presence 
of Isu1 support the role of these amino acids in SDU interactions.
129
  Additionally the 
presence of FRDA clinical mutants at residues L106, N146, Q148, W155, and R165 
provides further support for the importance of these residues in the proper in vivo 
function of FXN.
88
  While disruption of the protein secondary structure cannot be ruled 
out as a factor for the kinetic defects of the P150G and P163G variants, lack of such 
effects with the other proline residue (P117) suggests that these β-sheet residues play a 
role in the binding or activation of SDU. Despite the presence of modest binding or 
activation defects of the acidic patch residues on α1, the level of impairment is 
significantly lower than expected for mutation of the iron binding site of an iron donor 
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protein; thus further supporting the allosteric activator role of FXN previously proposed 
by Barondeau et al. 
22
   
 This improved understanding of FXN/SDU interactions must be considered in 
the development of new treatments for FRDA. Identification of the localized binding and 
activation hotspot on the β-sheet of FXN (residues N146, Q148, N151, Q153, W155, and 
R165), suggests that future drug design should be targeted to this region of the protein. 
We believe this to be a region that interacts with ISCU2 and residues E101 and D112 on 
the acidic path would interact with NFS1. In addition to the use of commercially 
available small molecule screening kits, the design of small cyclic peptides should be 
used to target the FXN hotspot.  Since W155 and R165 appear to be the most important 
residues for binding SDU, and Q148 and Q153 are most important for activation, these 
residues should be included in cyclic peptide design. Finally this bank of FXN alanine 
scanning variants should also be applied to elucidating the FXN residues involved in 
interactions with the cluster transfer proteins.  
Conclusion 
FXN has been linked to the neurodegenerative disease Friedreich’s ataxia 
(FRDA), which is the primary focus of current therapeutic efforts. Mutagenesis 
experiments were designed in which the FXN surface residues were replaced with 
alanine or glycine (proline residues) and the resulting variants were tested in binding and 
activity assays.  These experiments revealed a localized hotspot, which included residues 
Q153, W155, and R165 that appear to be the most affected in binding and Q148 and 
Q153, which were severely affected in activity. This hotspot contains residues that are 
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all linked to FRDA and discovering the nature of the residues on the surface of FXN 
could aid in designing small peptide mimics for FRDA therapeutics.   
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CHAPTER V 
CONCLUSION 
 
In summary, we provide data that support a role for human FXN in accelerating 
the PLP-based chemistry of the cysteine desulfurase NFS1 and also in the interprotein 
sulfur transfer between NFS1 and scaffold protein ISCU2. Using enzyme kinetic studies 
and radiolabeled substrate, we have determined the catalytic cysteine on NFS1, 
generates a persulfide that is directly transferred to C104 on ISCU2. C104 is buried on 
an α-helix, so we believe this persulfide transfer event must be coupled to a helix-to-coil 
transition in order to expose C104 on ISCU2 to accept the persulfide sulfur. 
Additionally, evidence has been provided that the persulfide species transferred from 
NFS1 to ISCU2 is viable in Fe-S cluster assembly and can be transferred to apo 
ferredoxin. These studies are consistent with the mechanism of Fe-S cluster biosynthesis 
being sulfur first; ISCU2 can accept the persulfide sulfur in the absence of iron, 
following a transfer of persulfide from C104 to other cysteine residues on ISCU2, then 
ferrous iron can bind, and lastly, the sequential 2-electron reduction of each sulfane 
sulfur atom is required to complete cluster formation.   
To further study the mechanism for Fe-S cluster biosynthesis, we designed 
experiments to determine the type of cluster the SDUF complex could synthesize. This 
became a challenging project due to the Fe
2+/3+ 
and S
2-
 easily interacting in solution 
causing an Fe-S mineralization. This effect can cause proteins to aggregate with this Fe-
S mineralization resulting in a High Molecular Weight Species (HMWS) associated with 
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he complex that could also transfer to an apo target. This species can act as a chemical 
reconstitution for apo targets. We discovered through the use of gel filtration, CD, UV-
Vis kinetics, and Mössbauer that the complex could synthesize a [2Fe-2S] that was 
rapidly transferred from the complex to free ISCU2 or small molecule thiols. 
Fundamentally, in order to study the mechanism for Fe-S cluster assembly we need to be 
careful in studying an enzymatic reconstitution versus a chemical reconstitution. Future 
experiments need to introduce the natural reductant of ferredoxin, ferredoxin reductase, 
and NADH, and other components like the iron donor and chaperones. 
FXN has been linked to the neurodegenerative disease Friedreich’s ataxia 
(FRDA), which is the primary focus of current therapeutic efforts. Our group designed 
mutagenesis experiments in which the FXN surface residues were replaced with alanine 
or glycine (proline) and the resulting variants were tested in binding and activity assays. 
These experiments revealed a localized hotspot, which included residues Q153, W155, 
and R165 that appear to be the most affected in binding and Q148 and Q153, which were 
affected in activity. This hotspot contains residues that are all linked to FRDA and 
discovering the nature of the residues on the surface of FXN could aid in designing small 
peptide mimics for FRDA therapeutics. These in vitro results suggest FXN may have a 
physiological function as a regulator and that FXN levels control Fe-S cluster assembly. 
Such a function would be consistent with the generally accepted role for FXN in Fe-S 
cluster assembly and explain the loss of Fe-S enzyme activity phenotype upon FXN 
depletion. Future experiments will focus on testing and expanding upon this model with 
the ultimate goal of developing new strategies to treat FRDA. 
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                     Table A1. FXN Variant Activity Measurements w/o and w/ Fe
2+
 
Protein 
mol S
2-
/mol NFS1/min p test 
df=4 w/o  Fe
2+
 w/ Fe
2+
 
SDUF* 5.80 ± 0.51 9.70 ± 0.55 9.01 
H86A* 8.50 ± 0.03 10.70 ± 0.62 6.14 
D91A* 8.50 ± 0.70 8.80 ± 0.63 0.55 
E92A* 7.40 ± 0.50 11.20 ± 0.40 10.28 
E96A* 8.00 ± 0.40 10.00 ± 0.54 5.15 
R97A* 9.30 ± 0.30 16.01 ± 0.74 14.47 
E100A* 5.00 ± 0.80 6.80 ± 0.40 3.49 
E101A* 6.60 ± 0.36 7.60 ± 0.75 2.08 
D104A* 7.90 ± 0.39 10.50 ± 0.24 9.83 
S105A 4.38 ± 0.23 6.84 ± 0.15 15.52 
L106A 3.53 ± 0.35 5.78 ± 0.34 7.99 
E108A* 4.70 ± 0.70 7.00 ± 0.40 4.94 
E111A* 7.20 ± 0.04 7.90 ± 0.27 4.47 
D112A* 6.90 ± 0.72 8.00 ± 0.09 2.63 
D115A 3.18 ± 0.14 5.68 ± 0.30 13.08 
K116A 4.83 ± 0.16 7.24 ± 0.41 9.48 
P117G 2.82 ± 0.15 5.59 ± 0.24 16.95 
Y118A 3.98 ± 0.22 6.17 ± 0.40 8.31 
T119A 2.87 ± 0.12 6.22 ± 0.31 17.46 
E121A* 7.60 ± 0.50 9.60 ± 0.70 4.03 
D122A* 6.30 ± 0.30 7.40 ± 0.30 4.49 
D124A* 5.20 ± 0.07 7.20 ± 0.22 15.00 
S126A 2.64 ± 0.15 5.71 ± 0.15 25.07 
V131A 2.94 ± 0.37 4.86 ± 0.03 8.96 
T133A 4.80 ± 0.38 6.91 ± 0.34 7.17 
K135A 2.73 ± 0.42 5.80 ± 0.40 9.17 
T142A 4.32 ± 0.57 6.99 ± 0.57 5.74 
V144A 5.64 ± 0.72 9.34 ± 0.59 6.88 
N146A* 6.50 ± 0.41 7.44 ± 0.28 3.33 
Q148A* 2.50 ± 0.16 4.97 ± 0.08 23.88 
P150G 2.47 ± 0.16 3.36 ± 0.16 6.81 
N151A* 2.59 ± 0.26 7.36 ± 0.00 31.77 
Q153A
*
 2.30 ± 0.29 4.59 ± 0.31 9.29 
W155A* 5.46 ± 0.68 11.11 ± 0.17 14.03 
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        Table A1. FXN Variant Activity Measurements w/o and w/ Fe
2+ 
Continued 
Protein 
mol S
2-
/mol NFS1/min t test 
df=4 w/o  Fe
2+
 w/ Fe
2+
 
S157A 4.54 ± 0.27 8.12 ± 0.77 7.60 
P163G 3.08 ± 0.13 5.08 ± 0.21 14.03 
R165A 6.30 ± 0.22 8.55 ± 0.48 7.38 
D167A 3.63 ± 0.12 6.24 ± 0.01 37.54 
H177A 2.87 ± 0.18 5.92 ± 0.12 24.42 
D178A 2.18 ± 0.31 5.66 ± 0.12 18.13 
L190A 3.42 ± 0.36 6.81 ± 0.43 10.47 
K195A 4.13 ± 0.37 6.23 ± 0.23 8.35 
 
 
The p test was performed to see if there was a significant 
change in activity. In bold p>95% confidence, they are not 
different. * Indicates the experiment was performed by 
Nicholas Fox 
